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This dissertation research is comprised of three studies each examining the effects of 
chronic exercise, acute exercise, or oxidative stress on telomere biology.  Exercise 
training and physical activity have previously been associated with telomere 
maintenance, but the underlying mechanisms of this association are unclear.  The 
majority of studies to date have been performed in immune cells; however, the findings 
from these cells may not reflect telomere biology in other tissues.  Since exercise is a 
multi-organ stimulus we sought to describe the effect of exercise on telomere biology in 
multiple tissues, with a particular focus on skeletal muscle.  Study #1 showed that the 
effect of chronic voluntary exercise on telomere length in CAST/Ei mice is tissue 
specific.  Exercise was ‘telo-protective’ (i.e., maintained telomere length) in cardiac and 
liver tissues, while telomere shortening was observed in skeletal muscle of exercised 
animals compared to sedentary and young mice.  Study #2 was performed to elucidate the 
responses to acute exercise that could underlie the paradoxical response of telomere 
  
length in skeletal muscle to exercise training.  This study revealed that the MAPK 
pathway appears to be related to the expression of telomere binding proteins in response 
to acute exercise. In skeletal muscle, p38 MAPK mediated a decrease in gene expression 
of telomere binding proteins, providing insight into a possible mechanism for eventual 
telomere shortening in response to chronic exercise.  The results of study #2 indicate that 
the early cellular responses to exercise may accumulate (i.e., repeat bout effect) and 
underlie the shortened telomere length in skeletal muscle.  Study #3 sought to determine 
if reactive oxygen species were a plausible mechanism of telomere shortening in adult 
skeletal muscle fibers, as no mechanism to date has been elucidated for telomere 
shortening in this tissue.  Study #3 showed that oxidative stress is a potent telomere-
shortening stimulus in skeletal muscle fibers of mice and that telomere binding protein 
expression was also significantly affected by oxidative stress.  In total these results 
indicate that although chronic exercise attenuates telomere shortening in most tissues, 
skeletal muscle demonstrates a unique contradictory response likely due to its reaction to 
oxidative stress.  
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Chapter 1:  Introduction and Specific Aims 
Background 
As of 2009, 39.6 million people over the age of 65 years live in the U.S. (1) 
representing about 13% of the total population.  By the year 2030 this group is expected 
to grow to about 19% of the population, due in large part to advances in hygiene and 
modern medicine. Despite these advances and the ability to delay diseases of aging, 
interventions to delay or prevent the aging process itself are lacking and the underlying 
science of aging remains incompletely understood.  Some interventions can impact the 
aging process, including caloric restriction, which increases mean lifespan in rodents and 
humans (2), and long-term voluntary exercise training, which can delay aging in rodents 
(3).  Exercise training has also been shown to reduce all-cause morbidity and mortality, 
though evidence is lacking for the cellular and molecular determinants of how exercise 
delays aspects of aging thus leading to an improved ‘health-span’. Understanding how 
exercise alters the trajectory of aging may elucidate new therapeutic targets to intervene 
on the aging process.   
Telomeres are recognized as a biomarker of aging due to the end-replication 
problem, in which chromosomal DNA is shortened slightly with each replication.  
Telomeres and the many related proteins that assist in maintaining telomere length have 
been the focus of intense research in aging and cancer.  Telomeres not only play a role in 
determining the replicative capacity of cells but also maintain chromatin structures that 
are vital to transcriptional control (4), thus having relevance to both replicating and non-
replicating tissues (e.g., skeletal muscle).  Environmental factors (e.g., diet, physical 
activity, psychological stress) have recently been shown to alter telomere biology.  
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Evidence is mounting that physical activity is a telomere-maintaining stimulus (5-9), 
which may explain one means by which chronic exercise delays aging and age-related 
disease.  Much of the research on environmental influences on telomeres has focused on 
replicating cell types such as peripheral blood mononuclear cells; however, in post-
mitotic tissues the role of telomeres and their response to environmental stimuli is less 
understood.  In post-mitotic tissues such as skeletal muscle (10,11) telomere shortening 
may occur due to non-replication linked mechanisms, such as oxidative stress.   
In preliminary studies leading to this dissertation, we observed diametric 
responses of telomere length in skeletal muscle compared to cardiac tissue in animals that 
voluntarily exercised for 44 weeks (1 year old animals).  Skeletal muscle telomere length 
decreased in the exercised animals compared to age-matched sedentary and young 
animals, while in cardiac tissue telomere length was maintained in exercised animals 
compared to age-matched sedentary animals.  These data led to several questions:  Why 
does a post-mitotic tissue such as skeletal muscle respond to endurance type exercise 
with telomere shortening while telomere length is maintained in response to exercise in 
cardiac tissue (also traditionally viewed as post-mitotic)?  Could the response of skeletal 
muscle be due to repeated bouts of exercise, with the initial bouts resulting in unrepaired 
damage to the telomere or alterations in telomere biology leading to subsequent telomere 
shortening after many bouts?  What are the regulatory factors or signals activated in acute 
exercise that might lead to this counterintuitive response in skeletal muscle?  
The overall aim of this dissertation research was to determine the effects of 
chronic and acute exercise or oxidative stress on telomere dynamics in multiple tissues 
with a focus on skeletal muscle and its paradoxical telomere shortening in response to 
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chronic exercise.  The studies examined telomere length, several telomere length 
maintaining proteins (i.e., shelterin components), and proteins known to be associated 
with telomeres.  In addition we investigated the possible involvement of exercise-induced 
signaling proteins in telomere responses.  First, we focused on how telomere length, 
telomerase, and shelterin components changed in response to chronic exercise.  Next, we 
determined the response of shelterin to acute exercise and possible signaling mechanisms 
that could explain why skeletal muscle telomere lengths responded differently to chronic 
exercise.  Finally, we tested oxidative stress as a possible mechanism of telomere 
shortening in isolated adult skeletal muscle fibers.   
 
Specific Aims 
Specific Aim 1.  To determine the effect of chronic exercise on telomere length and 
telomere maintaining proteins in mouse cardiac, liver, and skeletal muscle tissues.   
 Study #1 explored the effects of chronic exercise in short telomere mice 
(CAST/Ei) across multiple tissues (Ludlow et al. under review at Journal of 
Gerontology: Biological Sciences).  Three groups of animals were used to determine the 
effect of age and chronic voluntary exercise (44 wks of exposure by 1 yr of age) on 
telomere length, telomerase enzyme activity, telomere binding protein content, and gene 
expression of several factors associated with telomere biology in skeletal muscle, cardiac 
muscle and liver tissue.  Animals were separated into groups of baseline (8wk, 
sedentary), 1 year old sedentary (SED-1yr) and 1 year old exposed to 44 wks of voluntary 
wheel running (EX-1yr). We hypothesized that telomere length would decrease in the 
sedentary animals after one year in myocardium and liver, and that exercise would 
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attenuate decreases in these tissues.  In skeletal muscle we hypothesized that telomere 
length would not change with age but rather remain unchanged with exercise training.   
 
Specific Aim 2:  To determine the effect of acute exercise on telomere maintaining 
proteins such as telomere binding proteins in mouse skeletal muscle tissues. 
 Study #2 investigated the effects of acute endurance type exercise (treadmill 
running) on the expression of telomere length regulating genes and mitogen-activated 
protein kinases in skeletal muscle. This study was done to begin to understand why 
telomere length in skeletal muscle shortens in response to exercise training.  Since the 
adaptation of tissues to exercise is in part the accumulation of repeated bouts of exercise 
and transient alterations in homeostasis, understanding the signals generated during acute 
exercise may provide insights into the underlying mechanism of the observations in study 
#1.  The initial gene expression response of key telomere length regulating protein to 
acute exercise is unknown.  The transient changes in gene expression induced by each 
bout of exercise may translate into altered protein levels and ultimately alter telomere 
lengths over time. We hypothesized that acute exercise would increase MAPK activation 
and be associated with decreased shelterin component gene expression in mouse skeletal 
muscle. We used an in vitro cell culture model to determine potential relationships 
between MAPK signaling and alterations in gene expression of the shelterin components. 
 
Specific Aim 3:  To determine the effects of reactive oxygen species on telomere 
length, telomerase enzyme activity and shelterin in skeletal muscle of two strains of 
mice differing by telomere length. 
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 Study #3 investigated the effects of reactive oxygen species (ROS) on skeletal 
muscle telomere length and telomere regulating proteins in two strains of mice differing 
in telomere length (CAST/Ei = short telomeres; C57BL/6 = long telomeres).  ROS has 
been shown to be a potent telomere-shortening stimulus in other tissues, but no data to 
date exist about the effect of ROS on telomeres in skeletal muscle fibers.  Telomeres not 
only play a role in the proliferative capacity of cells but also in genomic stability and 
maintenance of chromatin structure that is vital to transcription.  Thus understanding the 
effect of ROS in skeletal muscle fibers is an important step in elucidating the possible 
impact of ROS in the telomere shortening observed in adult skeletal muscle in response 
to chronic exercise. Isolated skeletal muscle fibers were treated with an oxidant, a 
combination of antioxidant and oxidant, or control conditions to determine if the 
observed effects were specific to the oxidative stress treatment.  We hypothesized that in 
isolated skeletal muscle fibers oxidative stress would decrease telomere length, increase 
telomerase enzyme activity, and increase protein content of telomere binding proteins.  
We also hypothesized that oxidative stress would induce less relative telomere shortening 
in CAST/Ei compared to C57BL/6 mice.   
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Chapter 2: Review of Literature 
This review of literature is structured into several sections to give an overview of 
basic telomere biology, the role of telomeres in aging, and the possible impact of 
environmental factors, in particular chronic exercise, on telomere length and telomere 
biology. First, a historical perspective outlines the first observations leading to the 
discovery of telomeres and the importance of telomeres in the aging process.  Following 
is a review of the basic biology of telomeres, the end-replication problem and the end-
protection problem.  Finally, a review of the literature concerning evidence of the 
associations of telomeres with age-related disease and physical activity is discussed, as 
well as the role of physical activity as a modifier of telomere dynamics.  
Historical Perspective of Telomeres 
Alexis Carrel, a Nobel laureate, was interested in cells grown in culture.  He 
established a line of chicken fibroblasts in 1908 that he cultured for 34 years, leading to 
the belief that cells in culture grew indefinitely (12).  This idea was challenged in 1961 
by results from Hayflick and Moorehead, when they observed that human skin fibroblasts 
grew in culture for 50 or so population doublings before undergoing what they termed 
cell senescence, or the Hayflick limit (13).  Further work by Hayflick showed that cells 
from older compared to younger individuals divided fewer times in culture (14).  Other 
scientists tried to reproduce Carrel’s fibroblast observations and were unsuccessful, 
which when combined with the results from Hayflick and other investigators, led to the 
acceptance of the idea that cells in culture can only divide a limited number times.  This 
also raised two important questions in cell biology, ‘What is the role of cellular 
senescence in human cells?  And is the limited capacity of cells to divide related to aging, 
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or is it a tumor suppressing mechanism?’  These basic questions, and the evidence from 
the investigations trying to answer these questions will be outlined in the following 
section.   
Working separately but at about the same time, James Watson (1972) (15) in the 
United States and Alexel Olovnikov (1973) (16) in then the Soviet Union, both 
hypothesized that the ends of linear chromosomes should shorten due to the action of 
DNA polymerase, a process later known as the ‘end-replication problem’.  Alexel 
Olovnikov hypothesized that the chromosome end shortening may be responsible for the 
Hayflick limit. 
 Barbara McClintock initially recognized the importance of chromosome ends in 
that without some protective mechanism, chromosomes would stick together and cause 
cellular dysfunction.  At about the same time but working separately Hermann Muller 
recognized that something at the end of a chromosome gave the DNA stability and coined 
the term, ‘telomere’ from the Greek words meaning  ‘end’ (telos) and ‘part’ (meros) (17). 
Chromosome ends where later sequenced by Nobel winner Elizabeth Blackburn who was 
interested in the structure that allowed DNA to be maintained as a linear chromosome 
(18).  In 1985 working in Elizabeth Blackburn’s lab, Carol Greider discovered the 
enzyme that maintains chromosome ends known as telomerase (19).  In addition, it was 
observed that telomeres were conserved across many species and that in mammals 
telomere length is tissue specific (20).  Since these early observations our understanding 
of telomeres and telomere biology has greatly increased.   
Basic Aging Cell Biology 
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The continuity of life rests on the fact that cells must divide to reproduce.  A cell 
undergoes an orderly process in which it duplicates all of its cellular components and 
then splits in two.  The cycle of duplication followed by division is known as the cell 
cycle.  The cell cycle consists of five distinct stages that are tightly regulated depending 
upon several factors not limited to nutrient availability and mitogen-stimulation.  The five 
stages are defined as M phase or mitosis, G1 phase or growth/ gap 1, S phase or synthesis, 
G2 phase or growth/ gap 2, and G0 or quiescence.  Collectively G1 through G2 are termed 
‘interphase’. 
Cyclins - Numerous proteins and protein kinases control the cell cycle and its 
progression.  The proteins consist of a family of proteins called cell division cycle genes 
(Cdc) or the cyclins.  The kinases that dictate the action of the cyclins are a family of 
proteins called the cylin-dependent kinases (Cdk).  To enter and exit each phase of the 
cell cycle a specific Cdc and Cdk interaction must take place in a highly ordered fashion 
for appropriate cell division.  In addition to the Cdc – Cdk interaction, a Cdk-activating 
complex is necessary for full activation of cell cycle specific events (21,22).  The major 
Cdc and Cdk partners are shown in Table 2.1.   
Table 2.1.  Cyclins and cyclin-dependent kinase partners in specific cell cycle 
phases.  Adapted from Table 17-1 from (23). Only vertebrate genes are shown. 
 
Cyclin (Cdc) Cdk partner Cell phase 
Cyclin D Cdk4, Cdk6 G1 
Cyclin E Cdk2 G1/S 
Cyclin A Cdk2, Cdk1 S 
Cyclin B Cdk1 M 
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Cell cycle inhibition – In certain cell types and under homeostatic stress (e.g., 
DNA damage) the cell cycle must be inhibited to allow for cellular damage to be repaired 
or for cells to undergo cell death, either spontaneous or programmed.  Two major 
families of proteins regulate inhibition of the cell cycle: the cip/kip family (CDK 
interacting protein/Kinase inhibitory protein) and INK4a/ARF (Inhibitor of Kinase 
4/Alternative Reading Frame).  The cip/kip family consists of p27, p57, and p21, which 
bind to cyclin-cdk complexes and arrest the cell cycle in G1.  The INK4a/ARF family 
consists of p16INK4a, p14ARF and p15, p18 and -19, which cause the cell to arrest in G1 
and are important in the response to cellular damage, particularly DNA damage.  Cell 
cycle inhibition is accomplished by these proteins binding to D-type cyclins.  An 
important cell cycle regulator that plays a role in cycle inhibition is tumor protein 53 
(p53) and proteins, p21 and p14 ARF that are activated by and prevent the degradation of 
p53, respectively.  The importance of these proteins lies in their tumor suppressor 
qualities; they have also been found to be highly associated with the DNA damage 
response at critically short telomeres (24,25).   
Cell cycle checkpoints – Cell cycle checkpoints have evolved to prevent damaged 
or incomplete DNA from being passed onto daughter cells.  The checkpoints allow the 
cell to verify that the necessary processes have accurately occurred before the cell 
progresses onto the next phase.  Important functions of some of the checkpoints are to 
recognize DNA damage via a sensor-signal-effector mechanism.  Since most cells in 
adult mammals are terminally differentiated, they must leave the cell cycle and enter G0.  
This permanent cell cycle withdraw occurs late in G1 at a point termed the restriction 
point (RP).  In cells that divide continuously throughout the life of a mammal, such as 
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hematopoietic and gut epithelial cells, RP is overcome via growth factor-induced 
expression of cyclin D that allows the enhanced interaction with CDK4 and continued 
cell division (23).  The G1 to S phase transition is governed by cyclin dependent kinase 
inhibitor p16 (p16 INK4a), which inhibits the interaction of CDK4/6 with cyclin D.  In 
replicating cells CDK4-cyclin D phosphorylates retinoblastoma protein (RB) relieving its 
inhibition on E2F that controls the expression of cyclin E.  Once cyclin E is expressed at 
sufficient levels (i.e., under mitogen stimulation) cyclin E interacts with CDK2 and the 
cell can transition to S phase.  The next checkpoint is the G2 to M phase, in which the 
cell must ensure many factors are correctly in place, one of which being faithful 
replication of DNA.  Often DNA is damaged and the cell is arrested until this damage is 
repaired or the cell is removed via cell death.  This checkpoint is governed by the actions 
of checkpoint 1 and checkpoint 2 (Chek/Chk1 and 2).  Chk1 and 2 control the 
phosphorylation status of cdc25, which controls the transition from G2 to M phase.  In 
addition, CHK2 and p53 interact and play an integral role in detecting DNA damage and 
determining cell fate (i.e., repair and transition or cell death) (21-23).   
Mechanisms of Aging – Many hypotheses of aging exist, most of which have 
focused on the role of metabolism and oxidative stress (26-28).  Oxidative stress, the 
production of reactive oxygen species (ROS) by oxygen metabolism, leads to damage of 
cellular components including DNA, lipids, and proteins (29).  Oxygen metabolism 
produces reactive oxygen species (ROS) such as hydrogen peroxide, superoxide radical, 
singlet oxygen, and hydroxyl (30).  Recently exciting new evidence has linked the free 
radical hypothesis and cellular senescence hypothesis (31).  The free radical and cellular 
senescence hypotheses will be discussed below.   
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Oxidative stress and aging – ROS has been implicated in several pathologies 
including cardiovascular disease, cancer, and recently in the aging process of skeletal 
muscle, as well as in several skeletal muscle pathologies (specifically cachexia) (32-34). 
Organisms are equipped with enzymatic and non-enzymatic defense systems to scavenge 
and deal with ROS (30).  These systems must maintain a balance between antioxidant 
and pro-oxidant stimuli and when pro-oxidants overwhelm antioxidants, damage to 
cellular components can occur.  Even in the healthiest organisms, oxidative damage is 
apparent.  Evidence from several model organisms indicates that life span can be 
extended with over-expression of one or more key enzymes involved in the protection 
against ROS (35,36).  In aged and diseased skeletal muscle an increase in superoxide 
production can occur due to an uncoupling at complexes I and III (37).  As a result of the 
increase in superoxide, mitochondrial bound Mn-superoxide dismutase converts the 
excess superoxide into hydrogen peroxide.  Also, a portion of the superoxide created at 
complex III is released into the mitochondrial intermembrane space and converted to 
hydrogen peroxide by Cn,Zn superoxide dismutase.  It has also been hypothesized that 
younger individuals can better or more efficiently respond to neutralize oxidative damage 
than older individuals.  Therefore, older cells will have a higher vulnerability to oxidative 
stress and tissue damage (30). In essence, the accumulation of oxidative stress and the 
deleterious effects of this damage to tissues lead to aging. This hypothesis was suggested 
by D. Harman nearly 60 years ago and is supported by many recent investigations (30).  
When a cell’s DNA and other biomolecules become damaged, programmed cell death, 
apoptosis, and the cessation of cellular proliferation leading to cell senescence may occur, 
resulting in an aged phenotype at the tissue and organ level. 
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Oxidative Stress and DNA - DNA within all cells of an organism is constantly 
under assault from endogenous damaging agents, estimated at tens of thousands of 
lesions per day (38).  Oxidative stress is known to induce multiple forms of DNA damage 
including base oxidation (specifically guanine) and single-strand and double-strand 
breaks (39).  When two single-strand breaks (SSB) occur in close proximity or when the 
DNA replication machinery encounters a SSB, double strand breaks (DSB) can occur 
(40).  In addition to strand breaks, oxidative insults result in various chemical 
modifications of guanine, such as the commonly studied 8-oxoguanine (8-oxodG) (41). 
Unrepaired 8-oxodG can lead to altered base pairing and mutations during DNA 
replication (42).  DNA insults that result in DNA damage can result in cellular 
senescence and apoptosis via p53 and p21 tumor suppressor pathways (39).  DNA 
damage repair is a series of complex systems that consist of sensors, mediators, 
transducers or effectors, and cellular responses (40).  Typical repair mechanisms include: 
base excision repair (BER), nucleotide excision repair (NER), non-homologous end-
joining (NHEJ) and homologous recombination (HR) (40).  DNA damage repair is 
regulated differently between cell types, progenitor cells preferring apoptosis over repair 
while terminally differentiated cells, such as adipocytes, neurons and skeletal muscle 
cells undergoing DNA damage repair more readily (43).  Terminally differentiated 
skeletal muscle myotubes seem to be deficient in BER compared to myoblasts, which 
leads to skeletal muscle DNA being hypersensitive to oxidative DNA damage (44).  
Narciso et al. (44) treated terminally differentiated skeletal muscle cells with H2O2 and 
observed significant increases in SSB, phosphorylated (Serine 139) histone 2A.X (γH2A.X) 
foci and inefficient repair.  These results indicate that myotubes (terminally differentiated 
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muscle cells) may accumulate DNA damage, which may become genotoxic and result in 
nuclei death that could lead to loss of muscle cell size, which could have important 
implications in aging and muscle wasting diseases.  
Certain regions of the genome are more sensitive to oxidative DNA damage, such 
as chromosome ends or telomeres. Telomeres are particularly susceptible to DNA 
damage because telomeres are G-rich (guanine triplet) and thus sustain more oxidative 
damage than the rest of the genome (45,46) and damage at the telomere has been 
implicated in aging related diseases and progeria conditions (41,47).  Further, SSB repair 
is deficient at telomeres (48); for these reasons telomeres are especially susceptible to 
oxidative-induced damage compared to the rest of the genome (45,46,49,50). 
Deciphering the role of oxidative stress in DNA damage, specifically at the telomeres, 
could have a profound impact on our understanding of several diseases, aging and 
progeria conditions.  
 Cellular Senescence and Aging - In contrast to the ROS model, another model of 
aging has been proposed by Kipling (51).  In his model there are three components to 
aged tissues: aged extracellular environments, aging of cells that are non-mitotic, and the 
aging of mitotic cells. Each of these areas contributes to overall human aging.  When 
cells that undergo division (i.e., mitosis) are removed from the body, they can only 
replicate a finite number of times before entering a senescent state (14).  This senescent 
state should not be confused with cell death, necrosis, or apoptosis. In this mitosis-
arrested state, (senescence) the cell is still metabolically active and can survive for many 
months or longer but is unable to replicate or repair damage (66). 
 Moorehead and Hayflick were the first to describe the cellular state of senescence, 
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though the mechanism was unknown.  Harley et al. (52) were the first to show that the 
mitotic clock was housed at the ends of linear chromosomes in the repetitive DNA 
element termed a telomere.  During in vitro aging, telomeres shorten with each 
population doubling until a critical length is reached and replicative senescence occurs 
(53).  Telomere length has been associated with aging in vivo as well (54-56).  Telomeres 
are said to act as a mitotic clock, keeping track of cell divisions until the critical length is 
reached and the cell enters replicative senescence (53). Thus, telomere length has been 
indicated as a novel biomarker of cellular aging. 
End-replication Problem 
Telomeres - Telomeres (5’-TTAGGGN-3’ up to several kilobases (kb) depending 
on species) are found on ends of linear chromosomes and protect the ends of DNA from 
damage and being recognized as damaged DNA (Figure 2.1).  Following the double 
stranded telomeric DNA region is a 50-400-nucleotide single-stranded 3’ overhang that is 
critical in end protection (57).  Telomerase, an enzyme that maintains telomere length 
homeostasis by adding 5’-TTAGGGN-3’ repeats to telomeres, uses the guanine (G) rich 
3’ overhang as a primer sequence in S phase of the cell cycle (58).  Telomere length, in 
cells lacking telomerase, is reduced with each cell division due to the inability of DNA 
polymerase to replicate telomere repeats, termed the ‘end-replication problem (57).  
Thus, telomere length has been proposed as a mechanism of cellular aging, due to the fact 
that when telomeres reach a certain length, cells in culture enter telomere-dependent 
senescence (critically short telomeres lead to senescence, where a cell is metabolically 
active but unable to repair damage or divide) (53).  Telomere length is tissue specific 
(i.e., telomere length within an organism will vary depending upon the tissue or cellular 
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population of investigation) and species specific (59).  Human telomeres are typically 5-
12kb in length (60) and mouse telomeres (consisting of the same sequence) are much 
longer (depending on inbreeding status and strain) up to 150kb (60).  In humans, the rate 
of telomere attrition is estimated at 30-150bp per year in leukocytes and fibroblasts (61).  
Telomere length is not a simple switch dictating cellular fate, but rather a dynamic 
system controlled by external cellular stimuli and numerous proteins.  Understanding the 
interplay of telomere length and telomere-associated proteins is critical to predicting 
cellular outcomes in disease states and understanding how this system responds to and 
deals with external stressors.  
 
Figure 2.1.  This figure shows a diploid chromosome, and an enlarged image of the 
chromosome end or telomere.  T-Loop and D-loop conformations are also presented 
along with various telomere-binding proteins.  Adapted from Figure 1 of Calado and 
Young (62).   
 
Telomerase – Telomeres and their length are not, however, static entities, but 
rather are dynamic (58).  In certain cells, the enzyme, telomerase, maintains and 
lengthens telomeres, allowing continued cell division beyond what would be expected in 
cells without telomerase.  Discovered in 1985 by Carol Greider working in Elizabeth 
Blackburn’s lab, telomerase is a reverse transcriptase that overcomes the end replication 
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tion, telomeres become extremely short and dys-
functional; end-to-end fusions ultimately cause 
chromosomal instability. Conversely, cells trans-
fected with the telomerase gene can proliferate 
indefinitely.10
To avoid the attrition of telomeres, germ-line 
cells and some somatic cells produce telomerase, 
an enzyme that catalyzes DNA synthesis to main-
tain telomere length. Telomerase reverse tran-
scriptase (TERT) uses the telomerase RNA com-
Figure!1.!Telomere!Structure.
As shown in Panel A, telomeres are located at the ends of linear chromosomes; they are composed of hundreds to 
thousands of tandem DNA repeat sequences: hexameric TTAGGG in the leading strand and CCCTAA in the lagging 
strand in humans. Protective proteins associated with telomere DNA are collectively termed shelterin (TRF1, TRF2, 
TIN2, POT1, TPP1, and RAP1). The 3! end of the telomeric leading strand terminates as a single-stranded overhang, 
which folds back and invades the double-stranded telomeric helix, forming the T loop. As shown in Panel B, telo-
meres can be directly visualized under the microscope at the ends of metaphase chromosomes (four telomere sig-
nals per chromosome) by fluorescence in situ hybridization (FISH). (Image provided by Peter Lansdorp, M.D., Ph.D.) 
Average telomere length can be measured by several methods: a technique that combines flow cytometry and FISH 
(flow-FISH), Southern blotting, and a quantitative polymerase-chain-reaction (qPCR) assay. Flow-FISH can measure 
the telomere length in different cell subgroups, such as granulocytes or CD4+ T lymphocytes; Southern blotting re-
veals length and length heterogeneity; and qPCR is a rapid assay that requires very small amounts of DNA. As 
shown in Panel C, the average length of telomeres in human leukocytes varies, ranging from approximately 11 kb at 
birth (in umbilical-cord blood) to 6 kb at 90 years of age. Telomere loss is most rapid early in life, and over a life 
span it is not linear but follows a third-order polynomial. Data are from Yamaguchi et al.6
Copyright © 2009 Massachusetts Medical Society. All rights reserved. 
Downloaded from www.nejm.org at UNIVERSITY SYSTEM OF MARYLAND on April 15, 2010 . 
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problem and inability of DNA polymerase to replicate or maintain telomeres (19). 
Telomerase (Figure 2.2) is a specialized reverse transcriptase consisting of two 
components; an RNA component, encoded by the gene Terc (telomerase RNA 
component) and a protein component, encoded by the gene Tert (telomerase reverse 
transcriptase) (63).  For telomerase to be functional and active both components must be 
expressed and present in the cell.  The Terc gene is typically expressed ubiquitously by 
cells while Tert is only expressed in cells that have telomerase activity (63).  In adult 
human skeletal muscle homogenates only very low levels of telomerase are detectable 
within the multinucleated fibers (64), while in C2C12 myoblasts telomerase is detectable 
(65).  In C2C12 cells differentiation of myoblasts to myotubes is believed to down-
regulate telomerase (66); however, under oxidative stress conditions the activity of 
telomerase is unknown in skeletal muscle.  In tissues other than skeletal muscle, 
telomerase has been observed to have alternative, non-nuclear functions under stressful 
conditions (67).   
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Figure 2.2.  The telomerase holoenzyme and various accessory proteins.  Telomerase 
is shown with TERC adding telomeric DNA to a chromosome end.  The telomerase 
holoenzyme and binding partners dyskerin, GAR, NOP10, and NHP2 are also shown.  In 
addition TERC is shown in its native RNA structure.  Adapted from Figure 3 of Calado 
and Young (62). 
 
End-protection problem 
The end-protection problem concerns how chromosome ends are recognized.  
McClintock described how normal chromosome ends were protected from being stuck 
together but broken chromosomes were not protected from joining (68).  Muller observed 
that chromosomes lacking their natural ends tended to fuse (68).  The next observations 
came much later when it was observed that when foreign linear DNA was introduced into 
cells it was unstable and recombined into the host’s genome (68).  This revealed that two 
T h e  n e w  e ngl a nd  j o u r na l  o f  m e dic i n e
n engl j med 361;24 nejm.org december 10, 20092356
follows in the first or second decade; aplastic 
anemia is usually fatal. There is variation in the 
clinical presentation, other organ systems may be 
involved, and pulmonary disease can be lethal.14 
A particularly severe variant of dyskeratosis con-
genita is the Hoyeraal–Hreidarsson syndrome of 
progressive pancytopenia, neurologic manifesta-
tions of microcephaly, ataxia, and growth retar-
dation in young children. Dyskeratosis congenita 
may occasionally be first diagnosed in midlife, 
with only minimally abnormal blood counts.15
Family studies led to the recognition of muta-
tions affecting telomere maintenance. Most cas-
es of dyskeratosis occur in boys. Genetic analy-
sis of multiplex pedigrees linked the phenotype 
to the Xq28 region, and the gene was named 
DKC1.3 The encoded protein, dyskerin, is a small 
nucleolar protein that binds to RNA (including 
Figure!3.!The!Telomerase!Complex!and!Its!Components.
The enzyme telomerase reverse transcriptase (TERT), its RNA component (TERC), the protein dyskerin, and other 
associated proteins (NHP2, NOP10, and GAR1) are shown. Telomerase catalytically adds TTAGGG hexameric nucle-
otide repeats to the 3!-hydroxyl end of th  telomeric leading strand, using a specific sequence in the RNA compo-
nent as the template. TERT contains three major domains: the N-terminal region, the reverse-transcriptase motifs, 
and the C-terminal region, all containing evolutionarily conserved motifs. TERC contains 451 nucleotides in seven 
conserved regions (CR1 through CR7), including the template (CR1), and an H/ACA box, a hairpin nucleotide se-
quence characteristic of a class of small nucleolar RNAs involved in RNA processing.
Copyright © 2009 Massachusetts Medical Society. All rights reserved. 
Downloaded from www.nejm.org at UNIVERSITY SYSTEM OF MARYLAND on April 15, 2010 . 
 
  18 
important mechanisms existed to deal with broken or exposed DNA ends: homology-
directed repair (HDR), and non-homologous end-joining (NHEJ) (68).  Next, it was 
observed that some mechanism prevented the natural ends of chromosomes from being 
recognized as broken DNA (68).  Thus the natural ends of linear chromosomes, 
telomeres, possess the ability to suppress kinases involved in recognizing broken DNA 
(ATM; ataxia telangiectasia mutated and ATR; ataxia telangiectasia and Rad3 related).  
In summary, the end-protection problem refers to that chromosome ends must have 
defenses against four separate pathways: ATM, ATR, NHEJ and HDR.  Failure to do so 
results in cell cycle arrest (ATM or ATR mediated), end-to-end fusions (NHEJ), or 
sequence exchanges (HDR).  Telomeres solve the end protection problem by associating 
with a six-protein complex termed shelterin.  Shelterin creates a protective DNA-protein 
cap on the end of chromosomes (68).  Telomeres are able to switch between a capped and 
uncapped state (58). When the telomeres are in a capped state telomere length is 
sufficiently long and able to fold back upon itself and bind to telomere binding proteins, 
forming a T-loop (69).  Telomerase is only able to add telomere repeats from the RNA 
template when the telomere is in an uncapped state (i.e., unfolded or no T-loop 
conformation) and the telomere is accessible to telomerase (69-72).  T-loops are formed 
by telomeres at the ends of chromosomes when telomere-repeat binding factor 2 (TRF2) 
is present (73).  T-loops are sequences of 5’-TTAGGGN-3’ repeated in a loop.  The 3’ 
single stranded Guanine-rich (G-rich) section of 150-300 nucleotides invades the 
telomere at complimentary sequences (termed D-Loop), forming a protective structure 
(73).  It has been shown that as little as 400bp are needed to assemble a fully functional 
telomere (69).  Further experiments have concluded that telomere length must be below 
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1kb to induce senescence in cancer cells and at least thirteen 5’-TTAGGG repeats are 
needed to prevent end to end fusions (69).  However, none of the above experiments 
tested whether these telomere features were sufficient to suppress a DNA damage 
response.  Attached to and essential for the formation of T-loops is the six-protein 
complex shelterin (69).  
Shelterin - Shelterin is a six-protein complex that protects chromosome ends from 
being recognized by the DNA damage response proteins (DDR), cell cycle checkpoints 
and inappropriate telomerase activity (Figure 2.3).  Specifically telomere-repeat binding 
factors 1 and 2 (TRF1 and TRF2), play critical roles in telomere biology and 
chromosomal stability.  TRF1 is a negative regulator of telomere length and is involved 
in mitotic progression (74), while TRF2 is crucial in maintaining the telomere ‘t-loop’ 
structure and preventing chromosome end-to-end fusions and chromosome abnormalities 
(69).  TRF2 is known to inhibit telomere end recognition by the DDR protein ATM, as 
well as inhibit recognition by the non-homologous end-joining (NHEJ) pathway (75). 
POT1 (with isoforms a and b in the mouse) is a telomere single-strand overhang binding 
protein essential for T-loop formation and is known to inhibit DDR recognition by ATR 
(76).  Other shelterin components that do not interact directly with telomeric DNA but 
interact through protein-protein inactions with TRF1, TRF2, and POT1 are TIN2 (TRF1 
– interacting nuclear protein), RAP1 (RAP1 GTPase activating protein) and TPPI/ACD 
(adrenocortical dysplasia homolog), respectively (69) (Figure 2.3).  Interestingly, 
shelterin can act as a negative regulator of telomere elongation, by inhibiting telomerase 
or activating telomere deletion (77,78).  If the integrity of the shelterin complex or the 
telomere cap is compromised, telomere shortening, cellular senescence and apoptosis can 
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occur (73,79,80).  As telomeres shorten, chromosomal destabilization and lack of 
recruitment of shelterin proteins results in loss of T-loop formation and uncapped 
chromosome ends (81).  This situation resembles double-stand DNA breaks and may 
activate the p53 or p16ink4a pathways leading to senescence or apoptosis (82).  
 
Figure 2.3.  Shelterin complex bound to telomeres in a T-loop conformation.  Shown 
are the six-shelterin proteins.  Telomere repeat binding factors 1 and 2 (TRF1 and 2), 
protection of telomeres 1 (POT1), telomere repeat binding factor 1 interacting protein 1 
(TIN2), RAP1 GTPase activating protein (RAP1), and Adrenocortical dysplasia protein 
homolog (ACD or TPP1) which interacts with TIN2 and POT1.  Image adapted from S. 
Savage (83). 
 
Non-replicative telomere shortening – Several studies have linked telomere 
shortening to high levels of ROS regardless of age of cell donor (84,85).  For example, 
Richter and von Zglinicki (86) used several well-established cell culture systems from 
donors of various ages (embryonic to adult) and showed that placing cells in different 
oxygen concentrations (a condition known to induce different levels of oxidative stress) 
resulted in differential rates of telomere shortening and eventually cell cycle arrest.  At 
very high ambient oxygen concentrations (40%) the cell line from the oldest donor 
(human skin fibroblasts from a 91yr old female) with the lowest antioxidant capacity was 
observed to only undergo three population doublings before perishing.  It has also been 
 
  21 
demonstrated that over-expression of extracellular superoxide dismutase can slow 
telomere shortening in a cell line with low antioxidant capacity and oxidative stress- 
induced telomere shortening thus extending the culture’s viability (87).   Under oxidative 
stress conditions it has been shown that in telomerase positive cells telomeres shorten as 
fast as telomerase negative cells; the reasons are suspected to be nuclear exclusion of 
telomerase and localization of TERT to the mitochondria, which protects mtDNA and 
lowers superoxide production resulting in less oxidative stress (88).   
As telomeres shorten, either from damage or replication, chromosome ends 
become unprotected (or uncapped) leading to a DNA damage response and growth arrest 
(52,77).  Interestingly when telomeres shorten, gene expression of several shelterin 
components is down-regulated (78).  That being said, all telomeres in a cell or nucleus do 
not need to be short for senescence to occur, as shown by Hemann et al. (89), as the 
shortest telomeres within the nucleus dictate cell fate.  These shortest telomeres become 
uncapped and are recognized by the DNA damage response machinery (90), referred to 
as telomere-damage induced foci (TIF) (80).  Telomeres become uncapped or 
dysfunctional when TRF2 is inhibited and excessive telomere shortening occurs in the 
absence of telomerase, thus creating TIFs that are indicated by DDR factors such as 
53BP1, γH2AX, Rad17, ATM and Mre11 localizing at the telomere (80).  Telomere 
dysfunction is related to a DNA damage response that is mediated by tumor protein 53 
(p53) leading to the transcriptional activation of CDK p21 (91-94) or p16 (95-97) both of 
which are mediators of senescence.  In a recent study by Chebel et al. (78), it was shown 
in serial cultures of lymphocytes that shelterin gene expression was markedly reduced 
with senescence, with TRF1 mRNA and protein decreased the most of any shelterin 
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component, while TRF2 did not change.  Also, the authors monitored the formation of 
TIFs throughout the cultures and observed an increased number of foci over time.  Thus, 
one could imagine a situation where oxidative damage and shortening of telomeres in a 
nucleus results in uncapping, loss of shelterin gene expression, and eventually senescence 
or cell death. A number of studies have indicated that telomere dysfunction plays a main 
role in the stress-induced senescence program and in cell death (39,98). 
Recently in neuronal cell culture (U373 cells), Pollicitia et al. (84) showed that 
HIV infection resulted in telomere shortening.  They hypothesized that the telomere 
shortening in neuronal cells after HIV infection was due to oxidative stress.  They were 
able to rescue the telomere shortening with the antioxidant N-acetyl-L-cysteine, 
confirming their hypothesis.  Telomerase activity was not affected by either HIV 
infection or antioxidant treatment.  Makpol et al. (99) cultured human skin fibroblasts 
from young and aged donors and showed that treatment with H2O2 resulted in significant 
oxidative DNA damage, telomere shortening and decreased telomerase enzyme activity.  
The telomere shortening and telomerase activity-lowering effects of H2O2 were blunted 
by pretreatment with alpha-tocopherol (vitamin E).  The authors speculated the alpha-
tocopherol could be activating transcription factors that up-regulate telomerase gene 
expression (c-Fos and Ap-1 binding to DNA sites) and thus maintain telomere length via 
telomerase.  Further, Spallarosa et al. (100) showed that several members of the MAPK 
family, specifically p38 MAPK and JNK, are involved in the regulation of shelterin gene 
expression in cardiomyocytes.  Specifically, p38 MAPK inhibition resulted in up-
regulation or rescue of TRF2 gene expression after cells were exposed to doxorubicin (an 
anticancer drug known to have cardiotoxic effects). In summary, cells respond to 
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telomere dysfunction in a cellular stress mediated pathway (i.e., MAPKs) resulting in 
senescence, which leads to a loss of functional tissue and nuclei that could add to an 
aging or disease phenotype.  In two recent studies by the Depinho group (101,102) 
further evidence for the importance of telomere length and aging phenotypes was 
demonstrated.  In a first study, they showed that when telomerase was re-expressed in 
short telomere mice (G4-6 TERT knock-out mice) tissue dysfunction was overcome.  
Interestingly they observed significant alterations in non-mitotic tissues such as the brain 
(101).  In the second study, short telomeres were linked to mitochondrial dysfunction.  
Extensive testing confirmed that short telomeres were the first step, prior to 
mitochondrial dysfunction, leading to increased ROS production and enhanced ROS 
induced telomere shortening and altered gene expression of important mitochondrial 
biogenesis genes (102).  These results underscore the importance of telomeres in genome 
stability and provide evidence of a unified hypothesis of aging.   
Telomere length has also been proposed as a potent tumor suppressing 
mechanism as well.  Since cells in culture have only a limited capacity to divide (20 – 40 
population doublings; (13)) and since it likely takes about 100 doublings or so to create a 
colony of cells with a second mutation, only having the ability to double 40 or so times 
would act as a potent suppression mechanism against tumor formation and outright 
malignancy (103).  Also the finding that telomeres are shorter from cells of older donors 
in vivo and that telomeres shorten in vitro with increased cell doublings (52,104) 
indicated that telomeres might count or keep track of the number of cell divisions a cell 
undergoes.  This finding was strengthened by evidence that overexpression of the 
catalytic subunit of hTERT was able to restore telomerase activity, maintain telomere 
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length, and eliminate a limit of cellular replication (105).  Additional evidence was 
provided when telomerase activity was abolished in tumor cells and proliferative capacity 
was reduced (105).  It is hypothesized that telomeres represent the crossroads for cells 
between proliferative aging and cancer.  In certain tissues, such as skeletal muscle, the 
telomere dogma is different. 
Telomeres and Skeletal Muscle - Skeletal muscle is unique in that it consists of 
multinucleated muscle fibers and multiple niche populations of singularly nucleated cell 
types, the most well characterized being satellite cells (106).  Skeletal muscle is also 
considered to be post-mitotic, with only the satellite cells actively dividing when new 
nuclei are needed within the skeletal muscle fiber.  When skeletal muscle satellite cells 
are activated to divide and incorporate into muscle fibers as new myonuclei, the fibers’ 
average telomere length is reduced (106,107).  The newly added satellite cell nuclei 
represent the nuclei with the shortest telomeres since these newly added nuclei would 
have been actively dividing over time (106,107).  Minimum telomere length in skeletal 
muscle is thus thought to represent the replicative history of satellite cells (108).  As 
such, over time skeletal muscle telomere length can change despite its post-mitotic 
condition (106,109,110).   
Thus, when measuring skeletal muscle telomere length, mean and minimum 
telomere length (i.e., the shortest of the lengths observed in a tissue sample), representing 
fiber telomere length and satellite cell telomere length, respectively, must be analyzed 
and interpreted correctly (106).  A recent investigation showed that skeletal muscle 
telomere length was reduced in elderly individuals compared to young controls, as well 
as a modest trend for shorter skeletal muscle homogenate telomere lengths in sarcopenic 
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compared to non-sarcopenic individuals (111).  Other studies in skeletal muscle have 
focused on the replicative potential and regenerative capacity of satellite cells rather than 
skeletal muscle per se.  For example, Wernig et al. (112) studied the regenerative 
capacity of satellite cells and showed a slight decrease in mean telomere length with age 
in those cells, corresponding to reduced regenerative capacity. Data from several 
different muscular dystrophies indicate shortened satellite cell and skeletal muscle 
homogenate telomeres and telomere-related dysfunction associated with the muscle 
degradation and atrophy (110,113,114).  When considered together, these studies indicate 
that skeletal muscle telomere length can change, and moreover that using diseases such as 
muscular dystrophies as extreme skeletal muscle remodeling models may provide an 
avenue to understand the complex skeletal muscle telomere biology landscape.   
Methods of telomere length determination – Several methods of determining 
telomere length have been developed over the years.  Terminal restriction fragment 
(TRF) analysis by Southern blot, quantitative in-situ hybridization (Q-FISH), Flow-FISH, 
and quantitative PCR (qPCR).  There is an ongoing debate in the field as to which 
method is the most accurate, with each method having several limitations.  For instance 
the TRF Southern method is hindered by the remaining sub-telomeric DNA in the 
variable sequence region of the chromosome end, thus leading to inaccurate telomere 
length estimates (115).  The qPCR method has also been recently probed and found that a 
curvilinear relationship to the ‘gold-standard’ TRF Southern may be more accurate (116).  
The Q-FISH and Flow-FISH techniques are hindered by several factors including the 
need for high numbers of cell nuclei and labor intensive and highly sensitive techniques.  
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As of right now the two most common telomere length measurements are the qPCR and 
TRF Southern blotting techniques.   
Genetic component – Telomere length is highly variable from individual to 
individual, suggesting a strong genetic component.  Heritability estimates range from 30 
to 90%, with the lower estimates likely being more accurate as they were derived from 
better-controlled studies (117,118).  Several genetic diseases are associated with 
shortened telomeres and recently have been shown to be linked to telomere-related genes. 
 Monogenic diseases such as dyskeratosis congenita and idiopathic pulmonary 
fibrosis have been identified as ‘telomere diseases’ (62).  In addition several of the 
shelterin components have recently been shown be mutated in several genetic diseases 
(119).  In addition studies have shown that promoter polymorphisms in the hTERT gene 
are related to telomerase enzyme activity, telomere length and to cardiovascular disease 
(120).   
Aging and Physical activity  
Aging is a complex biological phenomenon and the factors governing the process 
of aging and longevity are only beginning to be understood.  Physical inactivity increases 
the risk of several age-related diseases such as cardiovascular disease (CVD), 
hypertension, osteoporosis, stroke and type 2 diabetes (121).  Becoming or remaining 
physically active in old age has been shown to reduce the risk of morbidity and mortality 
from these age-related conditions (122,123). Moreover, multiple reports have revealed 
the lifespan extending potential of physical activity (PA) (3,124-126).  Consistently 
performed PA appears to slow the rate of cellular and molecular damage accumulation 
and blunt the decline in physiological function that is characteristic of the aging process 
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(127,128).  Despite these findings, the causal molecular and genetic links between PA 
and the reduction in age-related disease risk remain elusive.  A potential link between 
aging and increased disease risk is shortened and/or dysfunctional telomeres. The role of 
telomeres in several diseases of physical inactivity has recently been elucidated (129) and 
recent epidemiological and experimental evidence points to PA as being able to influence 
telomere biology (5,9,130). 
Telomeres and Physical Activity  
Recently, several reports, including one from our laboratory, have associated 
PA or exercise training with alterations in telomere length and/or the network of proteins 
that interact with telomeres (5-8,106,109,130).  These results provide evidence of a link 
between PA and aging at the cellular level, and indicate the possibility of a mechanistic 
link between the influences of PA in the attenuation of age-related diseases.  
Collins et al. (109) were the first to demonstrate an association of telomere 
length with physical activity when they reported excessive telomere shortening in skeletal 
muscle of endurance athletes with severe fatigued athlete myopathic syndrome (FAMS) 
compared to age- and training volume-matched athletes.  In a follow-up study by the 
Collins group, shorter minimum telomere lengths were observed in those endurance 
athletes with the highest number of years and hours spent training (7).  These results 
indicate that long-term endurance training by highly-trained athletes may be a significant 
stressor to skeletal muscle and/or satellite cell telomeres, as indicated by the shorter 
minimum telomere lengths.  
Beginning in 2008, a number of groups began to study the association of 
typical, moderate physical activity with telomere length in humans.  Ponsot et al. (131) 
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investigated skeletal muscle telomere length in physically active and inactive men and 
women in two age groups, young and old, and observed that telomere length was similar 
within an age group regardless of activity level, indicating that moderate PA is not 
detrimental to skeletal muscle telomere length.  In epidemiological studies by Cherkas et 
al. (5) and Ludlow et al. (130) a positive association between PA and leukocyte telomere 
length was observed up to moderate levels of typical PA, while high-levels of PA were 
associated with shorter PBMC telomere lengths (130).  Though these results were not 
replicated in a large Chinese cohort (132), the two studies provided the first evidence of a 
potential benefit of moderate PA on telomere biology.  Additional evidence was provided 
in a recent study in which physically active women had longer leukocyte telomere 
lengths compared to sedentary individuals, which the authors hypothesized was related to 
PA diminishing the potential influence of perceived psychological stress (54) on 
leukocyte telomere length (133).  A recently published study investigating telomere 
length and PA in adolescent males and females observed that African American females 
who spent more time performing vigorous PA had significantly longer telomeres than 
less active peers (134). 
Other investigations have attempted to associate telomere alterations to resistance 
exercise.  Kadi et al. (135) studied competitive powerlifters compared to recreationally 
resistance-trained individuals and both average and minimum telomere lengths of vastus 
lateralis muscle in the powerlifters were shown to be longer compared to the resistance-
trained controls.  In contrast, within the group of powerlifters minimum telomere length 
was inversely associated to personal records in the squat and deadlift, indicating that the 
greater the weight lifted in a maximum effort the shorter the minimum telomere length.  
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Though speculative, the long-term training in the powerlifters seems to have resulted in a 
protective effect on telomere length in skeletal muscle, while excessive training 
associated with elite-level performance may result in accelerated telomere shortening.   
Animal models have also provided evidence of a role of physical activity in 
modifying telomere biology.  Although rodents tend to have significantly longer 
telomeres compared to humans (60), the associated proteins and overall telomere biology 
between the species are similar, thus providing useful insights into possible regulatory 
mechanisms.  Werner et al. (9) recently showed that the cardioprotective effects of 
voluntary wheel running on cardiomyocytes was conferred by an exercise-induced 
increase in telomere binding proteins (shelterin) and telomerase enzyme activity mediated 
by the presence of telomerase protein component TERT, as well as IGF-1 and eNOS.  
Exercise was also shown to decrease markers of apoptosis and reduce gene expression of 
several cell cycle associated genes, showing that exercise induces an anti-apoptotic 
environment thus preserving functional tissue and delaying an aged phenotype (9).  
Cardiomyocyte telomere length itself was not different between exercise and sedentary 
groups but was different with age (3-months versus 18-months), indicating age-related 
telomere shortening.  In a follow-up study in aortic tissues of mice and mononucleocytes 
of humans, Werner and colleagues (8) again showed that exercise training increased 
telomerase enzyme activity, increased telomere binding protein and mRNA expression, 
and decreased levels of Chk2, p16, and p53 in mouse aorta.  These gene expression 
changes were again shown to be mediated by TERT, IGF-1, and eNOS in the aorta.  
Similar to the cardiomyocyte data, aortic telomere length was not altered by 3-weeks or 
6-months of voluntary wheel running but demonstrated age-related shortening (3-months 
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versus 18-months).  In the human arm of the study, the authors investigated young 
sedentary, young athletes, aged sedentary, and aged athlete groups for telomere-related 
outcomes.  Mononuclear cell telomere length was preserved in the aged athletes and was 
shortest in the aged sedentary individuals, and telomerase activity was greater in young 
and aged athletes compared to the age-matched sedentary individuals.  Telomere-repeat 
binding protein 2 (TRF2) expression was increased in the athletes compared to sedentary 
individuals, while cell cycle genes (e.g., p16, p53, Chk2) were reduced in the athletes 
compared to the inactive groups (8).   
In summary, these human and animal experimental and epidemiological results, 
most notably the papers by Werner and coworkers, indicate that exercise training is a 
potent stimulus to the telomere biology system, though influences on telomere length 
itself may not be seen unless the training is for a long duration (See Table 2.2).  The data 
also indicate the possibility that moderate PA may provide the greatest positive influence 











  31 
 
Table 2.2. Summary of studies investigating physical activity and telomeres. 
 
Author and Year Major Findings 
Human Skeletal Muscle   
Collins et al. (109) Shorter telomeres in FAMS subjects (VL) 
Ponsot et al. (131) Equal telomere length between sedentary and active individuals 
(VL) 
Kadi et al. (135) Longer telomeres (mean and minimum) in powerlifters compared to 
sedentary (VL) 
Human Leukocytes (WBC unless otherwise noted) 
Cherkas et al. (5) Longer telomeres in more active in individuals  
Ludlow et al. (130) Longer telomeres in moderately active individuals compared to both 
sedentary and high active (PBMC) 
Woo et al. (132) No difference in telomere length between active and sedentary 
Shin et al. (136) No difference in obese middle age women who under went 6 
months of aerobic exercise training compared to untrained obese 
controls 
Werner et al. (8) Longer telomeres in older athletes compared to sedentary older 
individuals (PBMC) 
Puterman et al. (133) Longer telomeres in active individuals with lowest psychological 
stress 
Zhu et al. (134) Longer telomeres in active adolescent African American females 
compared to less active peers 
Larocca et al. (6) Longer telomeres in older active individuals compared to sedentary 
peers 
Song et al. (137) Longer telomeres negatively correlated with biomarkers of aging 
and positively with lifestyle factors such as PA level, BMI and 
smoking status 
Rodent Tissues  
Radak et al. (138) No change in telomerase activity with swimming in rat skeletal 
muscle or liver 
Werner et al. (9) Increased telomere protection, reduced apoptotic signaling, 
elucidation of possible mechanisms with VWR in myocardium 
Werner et al. (8) Increased telomere protection, reduced apoptotic signaling, 
confirmation of possible mechanisms with VWR in aorta tissue 
VL = vastus lateralis.  PBMC = peripheral blood mononuclear cells.  PA = physical 
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Possible Mechanisms of Physical Activity-Induced Modifications of Telomere 
Biology 
Few studies have defined the direct cellular and molecular mechanisms of the 
effect of PA on the biology of aging, though as outlined above a slowing of telomere 
degradation may act as one potential mechanism.  The direct signaling pathways by 
which PA interacts with the telomere are not clearly delineated, though the work of 
Werner and colleagues has provided some initial insights.  In general, regular PA is 
thought to prevent and delay inactivity- and age-related disease through multiple 
mechanisms, with reductions in either oxidative stress (125) or inflammation (139) or 
both being key potential mediators.  These same pathways can be linked to changes in 
telomere biology, providing potential mechanisms by which PA influences telomere 
biology with downstream influences on disease development and progression.  
For example, exercise training increases antioxidant capacity via an increase in 
antioxidant enzyme activity (140-142).  Telomere shortening is exacerbated in numerous 
cell types due to oxidative stress (84,86,87,143).  Thus, telomere length may be 
maintained in moderately physically active individuals due to reductions in oxidative 
damage occurring to the telomere.  Telomerase is also responsive to oxidative stress and 
may be key to protecting cells from stress insults (67,144), so this component of the 
telomere system may also benefit from the reduction in oxidative stress associated with 
PA. 
In the studies by Werner and colleagues, a role for endothelial nitric oxide 
synthase has been described, such that the presence of eNOS, and assumed nitric oxide 
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(NO) bioavailability, is critical for the exercise-induced alterations to the telomere 
binding proteins in cardiomyocytes and aortic tissue in mice.  These findings indicate that 
exercise, mediated by the beneficial effects of NO, is able to confer oxidative stress 
resistance and lower levels of apoptosis in multiple tissue types via genome stabilization 
by an increased expression of telomere binding proteins and telomerase via activation of 
cell survival pathways.  Nitric oxide signaling via cGMP is able to activate several pro-
survival protein kinases including phosphatidylinositol 3′ kinase (PI-3K) and protein 
kinase B (AKT) (145).  These studies by Werner and colleagues also showed a role for 
IGF-1 in the activation of telomerase.  Recent epidemiological evidence indicates that 
older individuals with low circulating IGF-1 and free of overt disease have shorter 
leukocyte telomere lengths (146).  Since acute exercise stimulates expression of IGF-1 
from both skeletal muscle and liver, IGF-1 may be playing a role in the augmentation of 
telomere biology by exercise (147).  How the ”exercise signal” is transmitted via pro-
survival pathways to the telomere-related genes has not been defined; however, these 
recent findings have highlighted possible molecular underpinnings of the beneficial 
effects of exercise training on vascular health.  
Stress hormones such as cortisol and stress responsive pathways such as those of 
the mitogen-activated kinases (MAPK) have also been implicated in telomere biology 
(100,148).  For instance Spallarossa et al. (100) demonstrated that p38 MAPK was 
involved in the regulation of Trf2 gene expression in response to doxorubicin treatment in 
cardiomyocytes.  Acute exercise is known to activate MAPK signaling, though the effects 
of exercise training on MAPK are less clear (149).  So acute exercise may result in a 
repression of telomere binding protein expression, which is consistent with longer 
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telomeres (150).  The MAPK pathway should be investigated as a possible mechanism by 
which exercise can influence telomere biology.  
In addition to oxidative stress-related pathways, short telomeres may contribute to 
the chronic inflammatory phenotype associated with aging, as demonstrated recently in a 
study showing shortened telomeres implicated in the regulation of interferon-stimulated 
gene 15 (ISG-15) (151).  Lou et al. (151) used a customized microarray analysis of cells 
with short, normal and artificially elongated telomeres to elucidate genes differentially 
expressed in human skin fibroblasts and ISG-15 was clearly differentially expressed in 
relation to telomere length.  Several studies have linked the expression and secretion of 
ISG-15 to inflammation through its stimulation of the pro-inflammatory interferon, IFNγ 
(152,153).  These results point to a possible mechanism whereby shortened telomeres are 
causing an increase in inflammation (a condition associated with many age-related 
diseases), thus contributing directly to the disease process.  A recent study using mTert-/- 
cells with shortened telomeres showed enhanced toll-like receptor 4 (TLR4) expression 
(154).  TLR4 mediates the inflammation process by stimulating the expression of NF-κB, 
which initiates the transcription of several pro-inflammatory genes such as Il-6, COX2 
and TNF-α.  Thus, shortened telomeres have been linked to a pro-inflammatory cellular 
environment and point to a possible protective effect of PA against telomere shortening 
through reduced inflammation-related gene expression. 
Both acute and chronic moderate exercise training are associated with beneficial 
changes in inflammatory makers (155,156).  Several inflammatory cytokines have been 
shown to be augmented in age-related diseases (e.g., TNF-α), and PA may blunt these 
age-related changes in inflammatory cytokines (157).  Short telomeres may initiate a 
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feed-forward mechanism resulting in the expression of both inflammatory and oxidative 
stress pathways that could accelerate telomere shortening and enhance age- and 
inactivity-related disease phenotypes.  PA may be exerting its anti-aging effects by 
protecting telomeres from shortening by improvements in antioxidant capacity and 
chronic inflammation.  
Determining whether or not telomere shortening is causing cellular dysfunction 
and age-related disease or if telomere length is simply a bystander reflecting the hostile 
cellular environment associated with age-related disease is a challenge.  The phenotypes 
of early generation Tert-/- and Terc-/- knock-out mice do not display telomere shortening 
as expected, but later generations of these animals have shortened telomeres and overt 
phenotypes such as CVD, indicating a direct link between telomere shortening and 
disease (4,158).  These and other knock-out animal models may provide insights into 
whether or not shortened telomeres are responsible for diseases of aging and inactivity.  
Other possibilities include engineering tissue-specific knock-out animals for components 
of the shelterin complex.  Whole-body knock-outs for Trf1 and Trf2 have been attempted 
but have not survived past the embryonic stage (74,80), showing vital roles for these 
proteins in development.  In contrast, tissue-specific (e.g., skin) shelterin component 
knock-out mouse strains produce viable offspring that display aging phenotypes and 
cancer (150,159).  Tissue-specific knock-out animals could be exposed to PA 
intervention studies to further elucidate the role of PA in telomere biology.  
Summary of Literature Review 
 In general there is sufficient evidence from the literature to conclude the 
following: 1) telomere length decreases with age in most cell/tissue types and this is 
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associated with many age-related phenotypes and diseases including cardiovascular 
disease and most cancers; 2) environmental factors such as psychological stress and 
physical activity/ exercise training are associated with altered telomere states (Figure 
2.3), with physical activity generally viewed as a ‘telo-protective’ stimulus. What is 
unclear is how exercise (or any environmental factor) is affecting telomere biology across 
a range of tissues, not just in immune cells.  Therefore a priority for advancing the field is 
to discern the effect of chronic and acute exercise on telomere biology in different 
tissues, both rodent and human.  In addition determining the mechanisms (signaling 
transduction pathways) by which exercise is affecting telomere biology could lead to 
novel therapeutic approaches to the aging process and possibly common age-related 
diseases such as cardiovascular disease.  The aims of the present dissertation contribute to 
our understanding of the impact of acute and chronic exercise on telomere biology in 
multiple tissues, in particular skeletal muscle.   
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Figure 2.4. The major factors leading to age-related disease or cancer phenotypes are 
shown. Interaction of genetic and environmental factors can lead to varying levels of 
DNA damage, oxidative stress, and inflammation, all of which can contribute to 
shortened or dysfunctional telomeres, depending on the extent of damage. Typically- 
shortened telomeres can result in cell cycle arrest, tumor suppression, and loss of 
functional tissue via senescence or apoptosis/necrosis and an aging phenotype. At the 
extreme, DNA damage (e.g., gene mutations) and subsequent activation of oncogenes, 
such as TERT and telomerase activity, can lead to age-related cancer. Becoming or 
remaining physically active may prevent or delay the onset of many age-related diseases 
and even some cancers, potentially through protection of telomeres. Figure reprinted 
from Ludlow and Roth (160).  
 
Rationale for the Present Dissertation Studies 
In order to partially inform the issues outlined above, the major goal of this 
dissertation work was to describe how telomere length and telomere associated proteins 
were responding to chronic and acute exercise.  In addition we sought to describe acute 
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binding protein expression, as these acute alterations may be critical to determining the 
outcome of chronic exercise on telomere length.  Finally we sought to determine if 
oxidative stress is a telomere-shortening stimulus in skeletal muscle fibers in the absence 
of satellite cells. 
 We have chosen to use two strains of mice for some of these experiments due to 
the large difference in telomere length between the two strains and the fact that biological 
differences between these two strains may exist in the response to ROS insult.  The 
suspected reason behind the large telomere length difference is the recent inbreeding of 
the CAST/Ei strain compared to the long-term inbreeding of the C57BL/6 strain (60).  
During stress, the regulation of genes that control telomere length may be differentially 
regulated in the two strains based on genotype and telomere length.  By using these two 
strains we can test for possible biological differences in the response to an oxidative 
challenge.   
 Hydrogen peroxide is a relatively stable compound and has only weak oxidizing 
potential, but with metal catalysis, such as Fenton’s reaction, hydroxy (OH-) radicals are 
formed which are highly reactive and damaging. During contraction H2O2 production is 
increased from various cellular sites including but not limited to the mitochondria (161) 
and xanthine oxidase (162). Physiological levels of H2O2 in skeletal muscle are achieved 
with extracellular doses ranging from 10µM to 100µM (163,164).  Also it has been 
reported that only approximately 7 to 10% of extracellular concentration of H2O2 actually 
permeates the cell membrane of skeletal muscle in culture (163,165), therefore an 
extracellular dose of 100µM would result in an intracellular concentration of 10µM.  
Similar treatment durations (5 days) have been used to investigate exercise-like 
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treatments in vitro (166) and single muscle fibers have been shown to be viable for this 
duration in culture (165).  Interestingly in a report by Anderson et al. (161) differences 
between rat skeletal muscle fiber type and production of H2O2 were observed.  At basal 
respiration rate, it was observed that H2O2 production was 3.5-fold higher in type IIb 
muscle fibers, and there were significant differences in the ability of the different fiber 
types to scavenge H2O2.  These data indicate that rodent skeletal muscle, particularly the 
mainly fast twitch muscles such as the EDL or FDB that may be particularly susceptible 
to oxidative insult via H2O2.  Also many studies have used exogenous H2O2 to stimulate 
exercise like effects such as glucose uptake (167,168).  While the application of 
exogenous H2O2 may not mimic all aspects of ROS induced exercise signaling, it is a 
useful tool in pinpointing certain aspects of signaling cascades, particularly in skeletal 
muscle considering that H2O2 is produced both at rest and during contraction.  The goal 
of this study is not to determine where the H2O2 originated from within the skeletal 
muscle, but to determine if ROS (H2O2) is a telomere-damaging compound in skeletal 
muscle. 
 N-acetylcysteine (NAC) is a non-specific antioxidant that supports glutathione 
production (169).  NAC has been commonly used in studies using skeletal muscle and 
has proven to be a potent ROS scavenger in skeletal muscle (170).  NAC has been 
observed to reduce the effects of ROS as potently or more potently than the addition of 
SOD plus catalase (superoxide and H2O2 scavengers), ebselen (a glutathione peroxidase 
mimetic), and MnTBAP (an SOD mimetic) (171).  Therefore NAC should be a sufficient 
ROS scavenger during my treatments to confirm or not that ROS is associated with the 
observed changes.  Also since H2O2 application can induce other forms of ROS (NO, 
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superoxide production) using a non-specific antioxidant will also prevent harmful effects 
from these unwanted treatment side-effects.  
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Chapter 3: Chronic exercise modifies age-related telomere dynamics in a tissue-
specific fashion. 
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Abstract 
We evaluated the impact of long-term exercise on telomere dynamics in wild-derived 
short telomere mice over one year.  We observed significant telomere shortening in liver 
and cardiac tissues in sedentary 1-year old mice compared to young (8 wk) baseline mice 
that was attenuated in exercised 1-year old animals. In contrast, skeletal muscle exhibited 
significant telomere shortening in exercise mice compared to sedentary and young mice.  
Telomerase enzyme activity was increased in skeletal muscle of exercise compared to 
sedentary animals but was similar in cardiac and liver tissues.  We observed significant 
age-related decreases in expression of telomere related genes that were attenuated by 
exercise in cardiac and skeletal muscle but not liver. Protein content of TRF1 was 
significantly increased in plantaris muscle with age.  In summary, long-term exercise 
altered telomere dynamics, slowing age-related decreases in cardiac and liver tissue, but 
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Introduction 
Telomeres are stretches of repetitive DNA (5’-TTAGGGn) at the ends of 
chromosomes that, in combination with telomere binding proteins, serve to protect DNA 
in this region from being detected as damaged (79).  DNA polymerase cannot fully copy 
telomere DNA during replication resulting in loss of telomere repeats.  The loss of 
telomere repeats over time leads to shortening of telomeres that can reach a critical length 
resulting in senescence or cell death (52,103).  In certain tissues, the ribonucleoprotein 
telomerase can maintain and/or elongate telomeres (172).  In addition telomeres are 
bound by a six-protein complex termed shelterin that functions to repress DNA damage 
signaling at the telomere, regulate telomere length, and telomerase action at the telomere 
(173).  Short telomeres have been associated with cancers and many age-related diseases 
(160).  Physical activity and chronic endurance exercise training are associated with 
delayed cellular aging (3,125) and decreased morbidity and mortality (122).  Longer 
telomere length is found in several tissues in individuals who regularly perform moderate 
levels of physical activity compared to sedentary peers (8,9,130,174).  This suggests a 
potential “telo-protective” effect of exercise, consistent with the data supporting the 
benefits of exercise on cellular aging.  However, there is a lack of evidence as to which 
components of the telomere system and other interacting proteins are underlying this 
observation.  Also, to our knowledge only two studies have examined mouse telomere 
biology and exercise in depth, those being focused on the myocardium (9) and vascular 
and immune cells (8).  Telomere length is tissue-specific (20) and exercise elicits a multi-
organ stimulus that may have unique outcomes depending on the tissue studied. 
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The purpose of the present study was to determine the effect of long-term (44wks) 
voluntary wheel running on telomere length, telomerase enzyme activity, and shelterin 
and DNA damage response (DDR) gene expression in three tissues commonly examined 
in relation to exercise adaptation (skeletal and cardiac muscles and liver).  We performed 
these studies in a unique mouse strain, CAST/Ei, that displays telomere lengths shorter 
than many strains and similar to humans in multiple tissues (60).  In the present study, 
three groups of mice were studied: baseline young animals (BL-8wk), and mice that 
either had access to a running wheel (EX-1Y) or no wheel access (SED-1Y) for forty-
four weeks from 8 wks of age to 52 wks of age.  Telomere length and related outcomes 
were measured in skeletal muscle, myocardium, and liver in all animals.  We 
hypothesized that telomere length would decrease after one year in myocardium and 
liver, and that exercise would attenuate any decreases.  In skeletal muscle we 
hypothesized that telomere length would remain unchanged with age and exercise.  We 
found that both telomere length and expression of telomere-related genes were altered in 
a tissue-specific fashion following chronic exercise exposure compared to the young and 
one-year sedentary animals.  
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Methods 
Animals and Exercise – All animal experiments were approved by the University of 
Maryland Institutional Animal Care and Use Committee and conformed to the National 
Institutes of Health’s Guide for the Use and Care of Laboratory Animals (NIH Pub. No. 
85-23, revised 1996).  Tissues from ten young (8-10 wk old) male CAST/Ei J mice were 
purchased for the BL-8wk group, and thirty additional (20 male and 10 female) seven-
week-old CAST/Ei J animals were purchased for the EX-1Y and SED-1Y groups 
(Jackson Laboratory, Bar Harbor, ME).  Animals were acclimated to the animal facility 
for one-week prior to being randomly assigned to either an individual sedentary cage (no 
wheel access, n = 15) or an individual exercise cage (wheel access, n = 15).  The animals 
were housed at 25ºC on a 12 hour light-dark cycle.  Animals were fed ad libitum 
laboratory mouse chow (Prolab RMH 3000, 5P00, LabDiet, Nestle Purina, Vevey, 
Switzerland) and given free access to water.  The exercise cage was equipped with a 
voluntary running wheel and monitor system (Lafayette Instruments, Lafayette IN).  
Body mass was monitored bi-weekly.  Only 16 males and 5 females survived the full year 
intervention thus 10 EX-1Y animals (8 males and 2 females) and 11 SED-1Y animals (8 
males and 3 females) were analyzed.  The running wheels were locked for 48 hrs and 
food was removed four hours prior to euthanasia to minimize any effects of acute 
exercise or feeding on outcome parameters.  Animals were isoflurane anesthetized and 
euthanized by heart dissection.  Tissues were weighed, frozen in liquid nitrogen and 
stored at -80ºC for subsequent analyses. 
Telomere Length Measurement – We used slightly modified qRT-PCR methods to 
measure telomere length (175,176), using genomic DNA isolated and quantified using 
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standard procedures (130).  Between 12.5 and 20 ng of total genomic DNA was added to 
a reaction mixture containing 1XSybr Green Master mix (Applied Biosystems, Carlsbad, 
CA), 220nM forward and reverse primers for the T (telomere) PCR and 301nM forward 
and 502nM reverse for the S (single copy gene) PCR.  Cycling conditions for the T PCR 
were 50ºC for 2 min, 95ºC for 10 min followed by 30 cycles of 95ºC for 10 sec and 
annealing at 56ºC for 1 min with data collection.  Conditions for the S PCR were 50ºC 
for 2 min, 95ºC for 10 min, 35 cycles of 95ºC for 15 sec, annealing at 56ºC for 1 min 
with data collection, extend 72ºC for 1 min.  For the T PCR we used the following 
primers (Tel 1 Forward 5’-GGT TTT TGA GGG TGA GGG TGA GGG T; Tel 2 
Reverse 5’- TCC CGA CTA TCC CTA TCC CTA TCC CT) and for the S PCR (acidic 
ribosomal phosphatase PO, 36B4; Forward 5’- AAC AAG GCA GGA GTG AGA CTG; 
Reverse 5’- CCA GGG ATA CGG GAG AAA A).  All samples were run in triplicate, a 
standard curve was run on every plate, and a reference sample was included to ensure 
linearity and consistency of assays.  Intra-assay coefficients of variation for T and S 
PCRs are as follows for each tissue: liver T PCR 1.1%, S PCR 0.9%; skeletal muscle T 
PCR 1.8%, S PCR 1.2%; Cardiac muscle T PCR 1.32%, S PCR 0.7%.  Inter-assay 
coefficient of variation for T PCR was 6.9% and for S PCR was 12.2%. 
To confirm the qRT-PCR method mean telomere length was measured by 
terminal restriction fragment (TRF) length analysis as described previously (177).  We 
used samples from heart and liver that represented the two longest and two shortest from 
the qRT-PCR method.  Briefly, 2µg of genomic DNA was digested overnight with Rsa1 
and HpaIII  (Roche, Indianapolis, IN) and electrophoresed on 0.7% agarose gels for 2hrs 
and visualized via ethidium bromide staining.  The gel was then electrophoresed for 
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16hrs at 60v to ensure adequate separation of DNA fragments.  The DNA was blotted 
onto positively charged Nylon membranes (Roche, Indianapolis, IN), heat cross-linked 
and hybridized overnight at 50ºC with the telomeric probe (digoxigenin 3′-end-labeled 5′-
(CCTAAA)3) and visualized using a chemiluminescence detection system (Syngene Bio 
Imaging, Frederick MD; Supporting Figure 3.1).  Mean, median, minimum and 
maximum TRFs were determined according to previous methods (178). 
Telomerase Enzyme Activity - Telomerase enzyme activity was measured using a 
commercially available kit (Quantitative Telomerase Detection Kit; US Biomax, 
Rockville, MD) that utilized the Telomere Repeat Amplification Protocol (TRAP) (179).  
To ensure reliability and validity of the assay, triplicate samples, as well as internal 
controls provided in the kit, were assayed.  Inter- and intra-assay coefficients of variation 
were calculated and compared to published data that used the same kit (intra- and inter-
assay coefficients of variation for gastrocnemius (10.1%, 12.6%), heart (3.7%, 5.5%) and 
liver (7.1%, 7.3%).  In addition we ran heat-treated negative samples and if the heat-
treated sample was at least three standard deviations above the positive sample, the data 
were accepted.  The telomerase data was analyzed as directed by the manufacturer and as 
previously performed in our lab (130).  Tissue samples were normalized for protein 
content prior to performing the telomerase assay.  Briefly, we used the bicinchoninic acid 
protein assay (Pierce, Rockford, IL) to normalize each sample to 0.43 µg of protein, as 
previously described (130,180).  Analysis was performed in one gastrocnemius, one-
quarter of powdered heart tissue (~20mg) and liver (~50mg) of all animals. 
Reverse Transcription-Polymerase Chain Reaction (PCR) – Total RNA was isolated 
using Trizol reagent (Invitrogen, Carlsbad, CA).  Reverse transcription was performed 
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with 1µg of total RNA using the high-capacity cDNA kit (Applied Biosystems, Carlsbad, 
CA).  PCR was normalized to Gapdh for all target genes and expressed relative to the 
baseline group.  Primer sequences for Trf1, Trf2, Ku70, Ku80, Chk2 and p53 are from (9) 
(Supporting Table 1).  Analysis was performed in one EDL, PLT, one-quarter of heart 
tissue (~20mg), and liver (~50mg). 
Western Blotting – For GAPDH, TRF1, and TRF2, one EDL (extensor digitorum 
longus), one PLT (plantaris), one-quarter of powered heart (~20mg), and liver tissue 
(~50mg) were homogenized in lysis buffer (100 mmol/ l Tris [pH 6.8], 4% sodium 
dodecyl sulfate [SDS], 20% glycerol and protease inhibitor cocktail (complete mini 
EDTA-free, Roche, Indianapolis, IN).  The protein concentration of the lysate was 
determined as described above and 30µg of protein was separated on 10% SDS-
polyacrylamide gels.  Proteins were transferred onto PVDF membranes (Immunobilon-P, 
Millipore, Billericka, MA) blocked in 3% NFDM for 30 min and exposed to primary 
antibodies overnight at 4ºC as follows: TRF1 (C-19, SC 1977, 1:200 in 1% NFDM, Santa 
Cruz Biotechnologies, Santa Cruz, CA), TRF2 (H-300, SC 9143, 1:200 in 1% NFDM, 
Santa Cruz Biotechnologies, Santa Cruz, CA) and GAPDH (Cell signaling, 14C10 Rabbit 
mAb # 2118 1: 1000 in 5% BSA, Beverly, MA).  In a portion of the gastrocnemius 
muscle from a subset of animals, mTERT was immunoprecipitated by using 500µg of 
protein and mTERT (SC-7212 H-231 rabbit polyclonal 1:200 in 1 % BSA, Santa Cruz 
Biotechnologies, Santa Cruz, CA) with agarose-A protein goat anti-rabbit IgG (Sigma 
Aldrich, St. Louis, MO).  All products were visualized using enhanced 
chemiluminescence (Pierce, Rockford, IL) and HRP as a substrate on the Gene Gnome 
(Syngene Bio Imaging, Fredrick, MD). 
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Statistical Analysis - 
Relative band intensities from agarose gels and immunoblots were analyzed using NIH 
ImageJ software (181).  All values, unless otherwise stated, are presented as mean ± 
standard error of the mean.  Pearson product-moment correlations were calculated to 
correlate the percent change of telomere length and TRF1 and TRF2 percent change in 
protein content in SED-1Y and EX-1Y animals.  Generalized linear models were used to 
analyze the data with SAS version 9.2.  Only omnibus p values are reported in the text of 
the results, specific contrast p values are reported in the figure legends.  We compared 
BL-8wk animals to SED-1Y animals to determine the effect of age and the effect of 
exercise was determined by comparison of SED-1Y and Ex-1Y animals.  All analyses 
were repeated considering sex as an independent variable and similar tendencies were 
observed (data not shown), thus we collapsed all data by sex for presentation purposes. 
We acknowledge that the small sample of females in our cohort should be considered 
exploratory, but we did not observe any effects of sex for any analysis.  Differences were 






  51 
Results 
Chronic exercise modifies age-related changes in telomere length and telomerase 
enzyme activity 
Twenty-seven CAST/EiJ mice were analyzed at two different ages and with or 
without access to a cage-mounted, computer-monitored running wheel for forty-four 
weeks. Skeletal muscles (gastrocnemius, EDL and PLT), cardiac muscle, and liver were 
studied from young 8-week old (BL-8wk, n = 6) mice, one-year old sedentary animals 
(SED-1Y, n = 11, standard housing conditions), and one-year old exercised animals (EX-
1Y, n = 10).  Mean voluntary running distance in the EX-1Y group was 6475 ± 1396 m/d 
(mean ± standard error) over the 1-yr intervention.  Body and heart masses were 
significantly smaller in the BL-8wk animals compared to the SED-1Y animals; 
gastrocnemius and liver masses were not different among groups (Table 3.1).  The 
differences in body and heart masses were expected and likely due to post-natal growth.  
Exercise did not change body mass, heart, liver, or gastrocnemius mass in comparison to 
SED-1Y (Table 3.1). 
Skeletal muscle (gastrocnemius) telomere length was not significantly different 
due to age (p = 0.7), but was significantly shorter in the EX-1Y animals compared to 
SED-1Y (p = 0.007; Figure 3.1.A).  In contrast, cardiac muscle and liver telomere lengths 
were shorter due to age (BL-8wk v. SED-1Y, p < 0.01 heart; p < 0.01 liver), and exercise 
significantly attenuated those decreases (EX-1Y v. SED-1Y, p < 0.01 heart; p < 0.01 
liver; Figure 3.1.A).  Telomerase enzyme activity was maintained at baseline levels in 
gastrocnemius muscle of EX-1Y animals compared to a significant reduction in SED-1Y 
mice (p = 0.02; Figure 3.1.B).  Telomerase reverse transcriptase (mTERT) protein 
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content was detected in skeletal muscles of EX-1Y and SED-1Y but was not statistically 
different between groups (p = 0.30, data not shown).  Telomerase enzyme activity was 
not altered by age or exercise in either cardiac muscle or liver (Figure 3.1.B). 
Chronic exercise alters the gene expression and protein content of some shelterin 
components in skeletal muscle 
To determine if telomere-protecting components were altered in skeletal muscle 
in response to exercise, we measured gene expression of several telomere length-
regulating genes.  We examined two different skeletal muscles, the PLT (mixed oxidative 
and glycolytic phenotype, located in the triceps surae and activated in wheel running 
behavior) and the EDL (glycolytic phenotype, anterior of leg, minimal activation with 
wheel running; (182). 
Plantaris – 
Gene expression of Trf1, Trf2, Pot1a and Pot1b (telomere repeat binding factor 1 
and 2, protection of telomeres 1a and 1b, respectively) were not different across the three 
groups (data shown in Figures 3.2.A, 3.3.A, 3.4.A and 3.4.B).  In addition to these 
shelterin components, several other proteins have been found to be transiently associated 
with telomeres, such as DDR heterodimer KU (KU70/KU80) (183).  Gene expression of 
Ku70 was not different among groups, while Ku80 gene expression was lower in SED-1Y 
compared to BL-8wk, and chronic exercise tended to attenuate this reduction (Ku70, p = 
0.10; Ku80, p < 0.01; Figures 3.5.A and 3.5.B; significance reported as omnibus ANOVA 
p value, contrast specific significance for age and exercise effects are reported in the 
figure legends for all gene expression and protein data).  These results reveal that 
exercise may up-regulate the expression of genes associated with DDR.  To investigate 
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whether chronic exercise resulted in altered gene expression of proteins critical to the cell 
cycle we measured p53 and Chk2; gene expression was not different across groups for 
either gene (Figures 3.6.A and 3.6.B).  We measured protein content of TRF1, TRF2 and 
GAPDH (normalization/ loading control) in plantaris.  TRF1 protein content tended to be 
higher in SED-1Y compared to BL-8wk (p = 0.06; Figures 3.2.B and 3.2.C); no 
differences were observed for protein content of TRF2 (Figures 3.2.B and 3.3.C). 
We also correlated the change in telomere length with the change in TRF1 and 
TRF2 protein content.  We hypothesized that as telomere length decreased with age, 
shelterin protein content would also decrease (184).  We did not observe any significant 
correlations of percent change in telomere length with percent change in TRF1 or TRF2 
protein content in the plantaris. 
Extensor Digitorum Longus – 
Trf1 and Trf2 gene expression was lower in SED-1Y compared to BL-8wk, and 
exercise blunted this age-related reduction (Trf1, p < 0.01; Trf2, p = 0.01; Figures 3.2.A 
and 3.3.A).  Pot1a and Pot1b gene expression was also lower in SED-1Y compared to 
BL-8wk, but no exercise effect was observed (Pot1a, p < 0.01; Pot1b, p = 0.14; Figures 
4.A and 4.B).  Ku70 and Ku80 gene expression was lower in SED-1Y compared to BL-
8wk, and exercise blunted this reduction (Ku70, p < 0.01; Ku80, p = 0.05; Figures 3.5.A 
and 3.5.B).  p53 and Chk2 gene expression tended to be lower in SED-1Y compared to 
BL-8wk, with a tendency for exercise to attenuate the age-related reduction (p53, p = 
0.08; Chk2, p = 0.06; Figures 3.6.A and 3.6.B).  TRF1 and TRF2 protein content 
(normalized to GAPDH) were not different among groups (p = 0.62 and p = 0.31, 
respectively; Figures 3.2.B and 3.3.B).  These data indicate that long-term voluntary 
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exercise is a potent telomere-altering stimulus both for telomere length and telomere-
related gene expression in skeletal muscle.  The different responses between skeletal 
muscle types likely stems from intrinsic (muscle fiber type composition) and extrinsic 
factors (neuronal activation levels) during wheel running (182). 
We observed a significant negative correlation between the percent change in 
telomere length and percent change in TRF2 protein content (r = -0.71, p = 0.02, data not 
shown) in the EX-1Y EDL.  This result did not support our hypothesis and indicates that 
the animals that lost the greatest percentage of telomere length maintained or increased 
TRF2 protein content.  This finding supports data showing that when TRF2 is 
overexpressed in vitro it results in telomere shortening (185).  We did not observe any 
significant correlations between the change in telomere length and the percent change in 
TRF1 protein content in EDL. 
Chronic exercise attenuated age-related alterations in gene expression of shelterin 
components in cardiac muscle  
In general, cardiac muscle showed reduced gene expression of telomere-related 
genes with age that were attenuated with long-term voluntary exercise.  Specifically, gene 
expression of Trf1, Trf2, Pot1a, and Pot1b were lower in SED-1Y compared to BL-8wk 
and this age-related reduction was blunted in EX-1Y for all four genes (all p < 0.05; 
Figures 3.2.A, 3.3.A, 3.4.A, and 3.4.B). Ku70, Ku80, and p53 exhibited similar 
responses, with BL-8wk gene expression higher than SED-1Y but not different from EX-
1Y (all p < 0.05; Figures 3.5.A, 3.5.B, 3.6.A).  A similar pattern was seen for Chk2 gene 
expression, but the differences did not reach significance (p = 0.07; Figure 3.6.B).  We 
measured TRF1 and TRF2 protein content (normalized to GAPDH) and did not observe 
 
  55 
any differences among groups (p = 0.76 and p = 0.59, respectively; Figures 3.2.B and 
3.3.B). 
Several significant correlations were observed in the heart for percent change in 
telomere length and percent change in TRF1 and TRF2 protein content in SED-1Y or 
EX-1Y animals.  We observed in SED-1Y animals a significant negative correlation (r = 
-0.76, p = 0.01) for telomere length and TRF1 protein content, and a significant positive 
correlation (r = 0.74, p = 0.01) for telomere length and TRF2 protein content.  In the EX-
1Y animals we observed a significant negative correlation (r = -0.74, p = 0.02) between 
change in telomere length and change in TRF1 protein content with no correlation for 
TRF2.  These data offer partial support for the hypothesis that as telomere length is 
reduced, shelterin components are also reduced; TRF2 and telomere length in the SED-
1Y animals were positively correlated, supporting our hypothesis.  However, similar to 
the skeletal muscle data, TRF1 protein content changed in the opposite direction of 
telomere length. 
Chronic exercise altered gene expression and protein content of some shelterin 
components and DNA damage response genes in the liver 
In liver, no significant differences were observed for gene expression of Trf1, 
Trf2, or Pot1a across any groups (Figures 3.2.A, 3.3.A and 3.4.A).  Gene expression of 
Pot1b tended to be lower in BL-8wk compared to SED-1Y (p = 0.06) with no difference 
in EX-1Y (Figure 3.4.B).  Gene expression of Ku70 was lower in EX-1Y compared to 
both BL-8wk and SED-1Y (p < 0.01; Figure 3.5.A) and a similar tendency was seen for 
Ku80 (p = 0.07; Figure 3.5.B).  No differences were observed for p53 or Chk2 in any 
comparison (Figures 3.6.A and 3.6.B).  We measured TRF1 and TRF2 protein content 
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and TRF1 tended to be higher in SED-1Y compared to EX-1Y (p = 0.09; Figure 3.2.C), 
while TRF2 was not different among groups (Figure 3.3.C). 
We did not observe any significant correlations between the change in telomere 
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Discussion 
 
We show for the first time that chronic voluntary exercise prevented age-induced 
decreases in telomere length in liver and cardiac tissue, but not skeletal muscle in 
CAST/Ei mice.  Rather, chronic exercise contributed to accelerated shortening in skeletal 
muscle.  We also observed significant alterations in gene expression of telomere-related 
genes providing evidence that physical activity is able to attenuate age-related changes in 
telomere dynamics in a tissue-specific manner.  When considered together, these findings 
help provide cellular explanations by which chronic exercise may attenuate the aging 
process.  Our results highlight the importance of the environment in the aging process 
and in particular the need to study telomere dynamics in tissues other than immune cells 
in response to exercise.  In addition this is the first time that CAST/Ei mice have been 
used to investigate the role of exercise on telomere dynamics and these results show that 
short telomere strains of mice may respond differently to exercise than long telomere 
strains of laboratory animals (8,9).   
Exercise attenuated age-related telomere reductions in cardiac and liver tissues yet 
induced telomere length loss in skeletal muscle 
The use of telomere length as a biomarker of tissue aging has become widely 
accepted in the literature.  Several studies have demonstrated reduced telomere length 
with age in both humans and rodents (56,186-188).  While is it well accepted that in most 
tissues telomere length decreases with age, limited information exists about interventions 
to blunt or slow this reduction.  Our results indicate that exercise may prevent or delay 
the reduction in telomere length in certain tissues.  In cardiac tissue of Wistar rats 
telomere length decreases to a greater extent compared to other tissues such as liver, lung, 
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kidney and brain (187).  The authors speculated that the telomere shortening was due to 
unrepaired oxidative damage to telomeres (189) or due to sub-populations of dividing 
cardiomyocytes (190).  In C57BL/6 mice significant telomere shortening was observed in 
cardiac tissue of 18-month-old compared to 6-month-old animals (9).  Our results are in 
agreement with these previous reports that cardiac tissue does undergo age-related 
telomere shortening in rodents and we report for the first time that long-term exercise 
exposure is able to attenuate the age-related telomere shortening in cardiac tissue of 
CAST/Ei mice.  We also observed age-related telomere shortening in liver of CAST/Ei 
mice, specifically.  Others have shown age-related telomere shortening in liver of rodents 
(186).  Similar to cardiac tissue, our data reveal that exercise attenuated the age-related 
telomere shortening observed in the liver of sedentary animals.  These data demonstrate 
that long-term exercise is able to alter the aging process at the cellular level and provide 
the impetus to pursue future mechanistic studies to determine how telomere length is 
maintained with age in certain tissues of exercised CAST/Ei mice.   
In the skeletal muscle of the exercised animals we observed significant telomere 
shortening.  Our data and that of others demonstrate that skeletal muscle telomeres do not 
shorten with age given the tissue’s post-mitotic status (191,192).  However, Collins et al. 
(109) measured telomere length in age-and training-matched endurance athletes with one 
group of individuals displaying fatigued athlete myopathic syndrome (FAMS) and 
observed shorter skeletal muscle telomere length in the FAMS group compared to the 
healthy athletes.  Rae et al. (7) reported similar findings in healthy individuals with 
skeletal muscle telomere length shorter in endurance-trained individuals who had been 
training for the longest (number of years) and for the greatest duration of time per week 
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(hours spent running).  Our data in the skeletal muscle of the CAST/Ei mice that had 
long-term access to running wheels support these previous findings that chronic exposure 
to exercise is related to decreased skeletal muscle telomere length.  Further, these data are 
evidence that telomere dynamics of skeletal muscle between humans and CAST/Ei mice 
are qualitatively similar. 
Several factors could have caused the tissue-specific response of telomere length 
to long-term exercise exposure.  A common hypothesis for non-replicative associated 
telomere shortening is unrepaired oxidative damage to telomeres (143,193).  Intrinsic 
differences in antioxidant enzyme levels could have resulted in poor skeletal muscle 
reactive oxygen species (ROS) scavenging while cardiac muscle and liver, which have 
higher antioxidant capacity than skeletal muscle, maintained redox balance and prevented 
oxidative damage to telomeres (194).  Future investigations are needed to directly test the 
tissue-specific response of telomere length to oxidative stress. 
To our knowledge this is the first investigation to report an increase in skeletal 
muscle telomerase enzyme activity with any type of exercise stimulus.  Our results are in 
contrast to those previously observed in rat skeletal muscle, where no alteration in 
skeletal muscle telomerase enzyme activity was observed in response to swimming 
training (138); however, differences in the nature of the exercise stimulus and the model 
organism could account for the different results.  Telomerase enzyme activity is known to 
be very low in resting skeletal muscle (112,195), but an increase in response to exercise 
could reflect satellite cell proliferation or other cells infiltrating exercised muscle. 
Increased telomerase activity could represent an adaptation to exercise, such that as 
telomeres shorten in exercised muscle the muscle cells may counteract the shortening by 
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transiently up-regulating mTERT and telomerase activity.  Additionally, recent evidence 
has shown nuclear-independent actions of mTERT, including a role in protecting 
mitochondrial DNA from oxidative insults (67,88). Exercise training is known to exert 
powerful beneficial effects on mitochondrial function (196), suggesting an intriguing 
possibility for an effect of exercise on mTERT being involved in skeletal muscle 
mitochondrial health.  Our results indicate that long-term exercise may be a telomerase-
activating stimulus in skeletal muscle. 
No change in telomerase activity was detected in liver or cardiac muscle with 
chronic exercise in CAST/Ei mice.  In contrast, Werner et al. (9) observed that six-
months of exercise increased telomerase activity in cardiac muscle in C57BL/6 mice.  
Several differences between the studies should be noted that may account for contrasting 
telomerase results: 1) we used a different strain of mice (short telomere versus long 
telomere mice), 2) our exercise intervention was six-months longer, and 3) our 
measurements were made in older mice.  Further, a recent report by Gomes et al. (197) 
provides evidence that species with longer telomeres respond differently to oxidative 
stress compared to species with shorter telomeres, highlighting the influence of telomere 
length on telomeric responses to various stimuli.  With regard to liver, ours is the first 
report to measure telomerase enzyme activity after a long-term exercise intervention. 
Radak et al. (138) measured liver telomerase enzyme activity in rats after short term 
forced exercise training and also observed that telomerase enzyme activity was not 
different.  Therefore we speculate that exercise is acting through a telomerase-
independent mechanism to maintain telomere length in liver tissues in short telomere 
mice.   
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Gene expression of shelterin is reduced after 1 year of age, and exercise 
blunted this age-related change 
Shelterin is a six-protein complex that binds and protects telomere ends (173).  
Telomere-repeat binding factor 1 (TRF1) is important in telomere length homeostasis and 
TRF2 is critical for T-loop formation, while both are negative regulators of telomere 
length (185).  The literature concerning shelterin genes and the effect of age is limited. 
Since it is well established that telomere length diminishes with age, we hypothesized 
that shelterin levels would show similar decreases.  We observed significant decreases in 
skeletal muscle and cardiac muscle gene expression of shelterin components that were 
counteracted by chronic exercise.  Although the magnitude of decrease in TRF1 and 
TRF2 protein content were not quantitatively significant in the EDL or cardiac muscle, 
the direction of change was similar to the change in gene expression.  This could indicate 
that at later ages the decrease in gene expression becomes apparent at the protein level, 
however we were unable to detect a decrease in protein content at our chosen time-point. 
Gene expression of Ku70, Ku80, p53 and Chk2 are altered with age and chronic 
exercise 
We observed that gene expression of DDR, p53 and Chk2 genes were reduced 
with age and this reduction was attenuated by exercise in skeletal muscle and cardiac 
muscle, but not in liver.  Different responses in gene expression between tissues to the 
exercise may be due to different intrinsic responses to training that have yet to be 
identified (194).  These gene expression changes may indicate that the risk of cellular 
dysfunction is increased with age and that exercise was able to attenuate this risk in 
certain tissues.  Interestingly, (137) showed in peripheral blood cells that a combination 
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of recently elucidated biomarkers of aging and specifically p16Ink4a levels negatively 
correlated with exercise duration indicating that exercise reduces cellular DNA damage 
and perhaps delays cellular aging.  Our data support these findings but demonstrate a 
tissue specific response to exercise training. 
A limitation of our work is that the majority of our findings are constrained to 
tissues that largely exist in a post-mitotic state.  In addition, the inclusion of additional 
time points with older animals could expand upon our findings, particularly with respect 
to the shelterin complex.  Future studies should target the relationship between cellular 
and functional changes with exercise and aging and potential mechanisms such as stress 
resistance, apoptosis, and various signaling pathways in these specific tissues.   
Summary 
Understanding how physical activity specifically alters telomere dynamics across 
a range of tissues and species is important to gain knowledge of how the environment can 
affect the aging process.  We report for the first time significant changes in telomere 
length, shelterin, DDR, and cell cycle related genes with age that are altered with chronic 
exercise, but in a tissue specific manner in CAST/Ei mice.  These data also support the 
use of the CAST/Ei mouse strain in the study of telomere dynamics compared to other 
long-telomere mouse strains.  The results of this investigation raise multiple questions 
about how exercise and age interact at the cellular and molecular levels among tissues 
and organ systems. 
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Table 3.1. Animal tissue weights and other phenotypes 
 
 Data are presented as means ± SEM. Overall = p value for overall ANOVA; Age is the 
comparison between BL and SED; Exercise is the comparison between EX and SED. BL 
- 8wk – baseline eight weeks of age; EX = exercise; SED = sedentary; 1Y = one year of 
age. 
  
Phenotype BL – 8wk EX – 1Y SED – 1Y p - values 
Overall Age Exercise 
Body mass (g) 12.9±0.45 
(n = 6) 
16.4±0.35 
(n = 10) 
16.9±0.34 
(n = 11) 
< 0.01 <0.01 0.28 
Voluntary running 
distance (m*d-1) 
 - 6475±1396 
(n = 10) 
- - - - 
Gastrocnemius 
mass (g)  
0.07±0.006 
(n = 6) 
0.07±0.007 
(n = 4) 
0.08±0.080 
(n = 3) 
0.59 0.35 0.38 
Heart mass (g)  0.08±0.006 
(n = 6) 
0.13±0.007 
(n = 4) 
0.12±0.008 
(n = 3) 
<0.01 <0.01 0.60 
Liver mass (g) 0.41±0.06 
(n = 6) 
0.57±0.05 
(n = 10) 
0.53±0.04 
(n = 11) 
0.13 0.12 0.59 
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Figure 3.1:  Telomere length and telomerase enzyme activity.  A. Telomere length 
(T/S ratio) of skeletal muscle (gastrocnemius), cardiac muscle, and liver from baseline 
(BL-8wk), exercise (EX-1Y) and sedentary (SED-1Y) animals. Skeletal muscle telomere 
length was not different between the BL-8wk and SED-1Y animals (p = 0.7), but was 
significantly different between the EX-1Y and SED-1Y animals (p < 0.001). Cardiac 
muscle telomere length was significantly different between BL-8wk and SED-1Y animals 
(p <0.001) and between EX-1Y and SED-1Y animals (p = 0.01). Liver telomere length 
was significantly different between BL-8wk and SED-1Y animals (P = 0.005) and 
between EX-1Y and SED-1Y animals (p = 0.003). * significantly different from BL-8wk 
and SED-1Y.  ** significantly different from BL-8wk and EX-1Y.  B. Telomerase 
enzyme activity in skeletal muscle (gastrocnemius), cardiac muscle, and liver from BL-
8wk, EX-1Y and SED-1Y animals (values normalized to baseline across tissues).  
Telomerase enzyme activity was different between EX-1Y and SED-1Y animals in 
skeletal muscle (P = 0.03) but was not different between any groups in heart or liver. * 
significantly different between EX-1Y and SED-1Y.  BL-8wk – baseline eight weeks of 
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Figure 3.2: Trf1 gene expression and protein content. A. Trf1 gene expression was 
significantly lower in EDL (overall p < 0.01; age p < 0.01; exercise p < 0.01) and cardiac 
muscle (overall p < 0.01; age p < 0.01; exercise p < 0.01) of SED-1Y animals.  Trf1 gene 
expression was not different in plantaris or liver tissues.  ** significantly different from 
baseline and exercise.  B. TRF1 protein content was not different in EDL or cardiac 
muscle.  There was a significant increase in TRF1 protein content in plantaris of SED-1Y 
animals compared to BL-8wk animals (overall p = 0.06; age p = 0.02; exercise p = 0.15). 
In liver TRF1 protein content tended to be greater in SED-1Y compared to EX-1Y 
animals (overall p = 0.09; age p = 0.33; exercise p = 0.03) C. Representative immunoblot 
images of TRF1 and GAPDH.  * significantly different between EX-1Y and BL–8wk. # 
different from EX-1Y.  BL-8wk – baseline eight weeks of age; EX = exercise; SED = 
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Figure 3.3: Trf2 gene expression and protein content. A. Trf2 gene expression was 
significantly lower in EDL (overall p = 0.01; age p < 0.01; exercise p = 0.07) and cardiac 
muscle (overall p < 0.01; age p < 0.01; exercise p < 0.01) of SED-1Y animals.  Trf2 gene 
expression was not different in plantaris or liver tissues. B. TRF2 protein content was not 
significantly different in any of the tissues analyzed.  EDL TRF2 protein content in SED-
1Y animals tended to be lower compared to BL-8wk young animals (overall p = 0.36; age 
p = 0.17; exercise p = 0.33).  C. Representative immunoblot images of TRF2 and 
GAPDH.  ** significantly different from baseline and exercise. BL-8wk – baseline eight 
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Figure 3.4: Pot1a and Pot1b gene expression. A. Pot1a gene expression was 
significantly lower in EDL (overall p < 0.01; age p < 0.01; exercise p = 0.50) and cardiac 
muscle (overall p < 0.01; age p < 0.01; exercise p < 0.01) of SED-1Y animals.  Pot1a 
gene expression was not different in plantaris or liver tissues. B. Pot1b gene expression 
was significantly lower in EDL (overall p = 0.14, age p = 0.05, exercise p = 0.62) and 
cardiac muscle (overall p < 0.01, age p < 0.01, exercise p = 0.02) of SED-1Y animals.  
Pot1b gene expression tended to be lower in liver of BL-8wk compared to SED-1Y 
(overall p = 0.06; age p = 0.03; exercise p = 0.05; Figure 8) but were not different in 
plantaris tissue. ** significantly different from BL-8wk and EX-1Y; * significantly 
different from BL-8wk. BL-8wk – baseline eight weeks of age; EX = exercise; SED = 
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Figure 3.5: Ku70 and Ku80 gene expression. A. Ku70 gene expression was 
significantly lower in EDL (overall p < 0.01; age p < 0.01; exercise p = 0.07) and cardiac 
muscle (overall p < 0.01; age p < 0.01; exercise p = 0.09) of SED-1Y animals.  Ku70 
gene expression was higher in liver of SED-1Y compared to EX-1Y but was similar to 
BL-8wk (overall p < 0.01; age p = 0.35; exercise p < 0.01).  No differences were 
observed in plantaris. B. Ku80 gene expression was significantly lower in EDL (overall p 
= 0.05; age p = 0.02; exercise p = 0.63) and cardiac muscle (overall p < 0.01; age p < 
0.01; exercise p < 0.01) of SED-1Y animals.  Ku80 gene expression tended to be higher 
in liver of SED-1Y (overall p = 0.07; age p = 0.70; exercise p = 0.07) compared to EX-
1Y. In plantaris tissue Ku80 gene expression was significantly lower in SED-1Y (overall 
p < 0.01; age p < 0.01; exercise p = 0.06). ** significantly different from BL-8wk and 
EX-1Y; * significantly different from BL-8wk. # significantly different from EX-1Y. 
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Figure 3.6: p53 and Chk2 gene expression. A. p53 gene expression tended to be lower 
in EDL (overall p = 0.08; age p = 0.06; exercise p = 0.06) and cardiac muscle (overall p < 
0.01; age p < 0.01; exercise p = 0.12) of SED-1Y animals.  p53 gene expression was not 
different in plantaris or liver tissues. B. Chk2 gene expression tended to be significantly 
lower in EDL (overall p = 0.06; age p < 0.01; exercise p = 0.01) and cardiac muscle 
(overall p = 0.07; age p = 0.03; exercise p = 0.67) of SED-1Y animals.  Chk2 gene 
expression was not different in plantaris or liver tissues.  * significantly different from 
BL-8wk. BL-8wk – baseline eight weeks of age; EX = exercise; SED = sedentary; 1Y = 
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Supplemental Information 
 
Supplemental Table 3.1. Gene Expression Primer Sequences. 
Primer Target Gene name Sequence 
Trf1 (9) F - 5'-CAT GGA CTA CAC AGA CTT AC 
R - 5'-ATC TGG CCT ATC CTT AGA CG 
Trf2 (9) F - 5'-TGT CTG TCG CGC ATT GAA GA 
R - 5'-GCT GGA AGA CCT CAA TAG GAA 
Pot1a F - 5'-CCC TGA ATC TAC TCA AGG AAG 
R - 5'-GAA GCG AAC AAT GTC TCC AA 
Pot1b F - 5'- CTT TAA GCC TCC GGC CTT AAG 
CAA AG 
R - 5'- CTT GGA CAT GAT TAT CAG CAA 
CGA CA 
Ku70 (9) F - 5'- GAG CAT CCA GTG TAT CCA GA 
R - 5'- CAG CAT GAT CCT CTT GTG AC 
Ku80 (9) F - 5'- TCA CAG TGT GCA GAC CAC CTG 
R - 5'- AAC TGC AGA GAG ATG CCA GA 
p53 (9) F - 5'- GGG ACA GCC AAC TCT GTT ATG 
TGC 
R - 5'- CTG TCT TCC AGA TAC TCG GGA 
TAC 
Chk2 (9) F - 5'- GCT GTG CTC TGA AGT AAC AAC 
R - 5'- GAA GTA GAG CTT ACA GGT GG 
Gapdh F – 5'- GTG TCC GTC GTG GAT CTG 
R - 5'- CCT GCT TCA CCA CCT TCT TG 
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Supplemental Figure 3.1.  Representative telomere restriction fragment southern blot.  To 
confirm our qRT-PCR telomere length assay two of the longest and two of the shortest 
telomere length samples from heart and liver tissues were digested and blotted as 
described in the methods section.  Long Liver = 20.2kb; Short Liver = 8.8kb; Long Heart 





  75 
 
Supplemental Figure 3.2.  Monthly running distance in the exercised animals.  Data are 
presented as mean ± standard error.    
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Abstract –  
Telomeres are repetitive DNA elements that protect chromosomes and shorten 
with age in most tissues. I n skeletal muscle, however, telomere length does not shorten 
with age but paradoxically shortens in response to long-term aerobic exercise training (in 
contrast to other tissues).  Previous results indicate chronic exercise is associated with 
altered expression of telomere binding proteins within the shelterin complex in skeletal 
muscle.  Shelterin regulates telomere length and acute changes in expression of shelterin 
components over time may lead to the exercise-induced telomere shortening in skeletal 
muscle.  Thus, we sought to determine whether acute exercise affects gene expression of 
specific members of the shelterin complex in mouse skeletal muscle.  Three groups of 
female C57BL/6 mice were studied, one control group and two groups that underwent a 
30 min treadmill running bout that were sacrificed either immediately following or 1-
hour after the exercise.  In response to the exercise bout, mRNA expression of telomere-
repeat binding factor one (Trf1) was reduced in plantaris muscle, but not in tibialis 
anterior muscle, and this reduction was paralleled by changes in p38 MAPK 
phosphorylation.  To determine if p38 MAPK mediated the decreases in Trf1 mRNA 
expression C2C12 myotubes were treated with calcium ionophore (A21387) and we 
similarly observed reduced Trf1 gene expression and phosphorylation of p38 MAPK.  
When C2C12 myotubes were treated in combination with a p38 MAPK inhibitor 
(SB202190) and A21387 no decrease in Trf1 mRNA expression was observed, indicating 
a link between Trf1 gene expression and p38 MAPK activation.  Thus, acute endurance 
exercise results in a decrease in Trf1 gene expression, which may be mediated by p38 
MAPK.  These data provide important mechanistic insights into the paradoxical telomere 
shortening that occurs in skeletal muscle in response to chronic exercise.    
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Introduction   
 Telomeres are specialized repetitive DNA sequences (5’-TTAGGGn -3’) found at 
the ends of linear chromosomes that play a protective role for the chromosomes (198).  
Common dogma is that in response to cellular replication telomere DNA is lost and the 
telomeres shorten, potentially contributing to the induction of cellular senescence 
(63,199).  In this sense telomeres are considered a biomarker of aging; however, in 
certain cell types the ribonucleoprotein telomerase maintains and lengthens telomeres 
(200), slowing the loss of telomere repeats and potentially delaying cellular senescence. 
In addition to maintaining the proliferative capacity of cells, telomeres act as an 
important contributor to genome stability and transcriptional regulation, thus indicating 
an important role for telomere length in post-mitotic tissues as well (201).   
Telomeres also function to protect the ends of chromosomes from end-to-end 
fusions and from being recognized as DNA damage (173).  To protect chromosome ends, 
telomeres form a T-loop chromatin structure (73) that is maintained by a six-protein 
complex termed shelterin (79).  Shelterin consists of three telomere-specific binding 
proteins and three accessory proteins that link the complex together and stabilize the 
DNA-protein interactions (79).  The three DNA binding proteins are: telomere repeat 
binding factors 1 and 2 (TRF1 and TRF2), and protection of telomeres 1 (POT1; POT1a 
and b in the mouse) (76).  TRF1 is critical in telomere length homeostasis and regulates 
cell cycle progression, while TRF2 helps form the T-loop structure and has telomere 
length regulating functions (185).  POT1 functions in regulating telomerase action at the 
telomere and also in maintaining telomere structure (41).  Additional linker and bridging 
proteins tie together the shelterin components and stabilize telomere ends (79).   
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In skeletal muscle the telomere shortening dogma does not hold true: skeletal 
muscle telomere length does not change with age, likely stemming from skeletal muscle’s 
post-mitotic and low cellular replication status ((191,192) Ludlow et al. under review).  
Recent evidence has shown that endurance exercise training may shorten telomere length 
in skeletal muscle ((7,109) Ludlow et al. under review.), which contrasts significantly 
from other tissues in which chronic exercise is thought to provide a ‘telo-protective’ 
effect and slow age-related telomere shortening (5,8,9,130,160).  Collins et al. (109) was 
the first to show that in age-and training- matched endurance athletes, skeletal muscle 
telomere length was shorter in those displaying symptoms of fatigued athlete myopathic 
syndrome (FAMS) compared to healthy athletes.  In a follow up study of healthy 
endurance-trained individuals, those who had trained for the greatest number of years and 
also had trained the greatest number of hours per week had the shortest skeletal muscle 
telomere lengths (7).  In addition, we have recently in CAST/Ei mice that one year of 
chronic exercise exposure resulted in shorter skeletal muscle telomere length compared to 
both young (8wk) and age-matched sedentary mice (Ludlow et al. under review).  In 
addition to telomere shortening in the exercised animals, we observed differences in gene 
expression and protein content of telomere length–regulating genes (i.e., shelterin 
components).  Together, these data indicate that telomere dynamics in skeletal muscle are 
unique and do not follow the pattern typical of other tissues in response to chronic 
exercise.  
Since skeletal muscle telomere length decreased in response to exercise training, 
we wanted to understand the initial signals induced by exercise that could lead to this 
paradoxical result.  Mitogen-activated protein kinases are tightly linked to mitosis and 
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have been implicated in cellular senescence (202-204).  The expression of shelterin 
components has recently been linked to the mitogen-activated protein kinase (MAPKs) 
family of signaling molecules, with p38 MAPK and JNK1/2 linked to the expression of 
Trf1 and Trf2 in cardiomyocytes (100).  Exercise, specifically skeletal muscle 
contraction, is known to activate several MAPKs (149), which are involved in regulating 
cellular responses to stress.  The terminal kinases in the MAPK signaling cascade are 
extracellular related kinase (ERK1/2), p38 MAPK, and c-jun n-terminus kinase/stress-
activated protein kinase (JNK1/2, SAPK) (149).  These proteins are broadly involved in 
processes such as cell death, differentiation, apoptosis, and cell cycle regulation (205).  
Exercise is a potent perturbation to homeostasis and results in a stress response in skeletal 
muscle that is, in part, mediated by MAPKs.   
Given the data demonstrating that chronic exercise results paradoxically in 
reduced telomere length in skeletal muscle, we sought to determine the effects of an acute 
bout of exercise on components of the shelterin complex. The purpose of our 
investigation was 2-fold: 1) to determine the effects of an acute treadmill exercise bout on 
skeletal muscle gene expression of shelterin components; and 2) to determine if a 
potential relationship could be established between MAPK signaling and any detected 
alterations in gene expression of the shelterin components.  We hypothesized that acute 
exercise would result in decreased skeletal muscle shelterin mRNA expression associated 
with activation of MAPKs. 
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Methods   
Animals – All animal experiments were approved by the University of Maryland 
Institutional Animal Care and Use Committee and conformed to the National Institutes of 
Health’s Guide for the Use and Care of Laboratory Animals (NIH Pub. No. 85-23, 
revised 1996).  Twenty-two female six-week old C57BL/6 mice were purchased (Jackson 
Laboratories, Bar Harbor, ME).  Animals were acclimated to the animal facility for one-
week prior to being randomly assigned to treatment groups.  The animals were housed at 
25ºC on a 12 hour light-dark cycle.  Animals were fed ad libidum laboratory mouse chow 
(Prolab RMH 3000, 5P00, LabDiet by Purina, Nestlé S.A., Vevey, Switzerland) and 
given free access to water.  Animals were separated into three groups for the experiment; 
BL (baseline, n = 6) animals were exposed to a motionless treadmill for thirty minutes 
prior to being euthanized.  The remaining sixteen animals underwent a 2-week treadmill 
acclimation protocol, peak speed test and were separated into two groups that underwent 
a 30min treadmill exercise bout and were euthanized either immediately following (time-
point one, TP1, n = 8) or one-hour after (time-point two, TP2, n = 8).  Skeletal muscles 
(plantaris and tibialis anterior) were dissected and frozen until processed and analyzed for 
gene expression and protein content.  
Treadmill acclimation protocol – The treadmill was set at a 7% incline for all 
treadmill sessions.  The animals were acclimated to the treadmill over a period of 
fourteen days consisting of four different sessions each repeated twice and separated by a 
day of rest, except for session four which was performed on 4 different days separated by 
a day of rest (Supplemental Table 4.1). 
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Incremental treadmill exercise test – Forty-eight hours after the last acclimation 
session, animals from the exercise groups were subjected to an incremental exercise test 
for assessment of their peak treadmill running speed. First, the mouse was placed for two- 
min on an immobile treadmill belt. Then, the test began at a speed of 6m/min and 
increased 3m/min every 2min until running ability was visually impaired as evidenced by 
the animal sitting on the shock pad for more than 30sec.  The speed of the last stage 
completed was recorded as the peak treadmill running speed.  
Acute treadmill exercise bout – Forty-eight hours after the incremental exercise 
test, the mice were exposed to 30 min of treadmill running at 65.5% (22.8 (3.6) m*min-1; 
mean (standard deviation)) of their peak speed (34.7 (4.6) m*min-1) and were sacrificed 
immediately (TP1; n = 8) or 1h following (TP2; n = 8) the running bout.   
Gene Expression – Total RNA was extracted using Trizol® (Invitrogen, Carlsbad, 
CA).  Briefly, one-µg of total RNA was reverse transcribed (Applied Biosystems, High-
capacity cDNA kit, Carlsbad, CA), followed by PCR and gel electrophoresis using 
previously published primers ((9) and Ludlow et al. under review).  
Immunoblotting procedures – Total protein was extracted from skeletal muscle 
samples with lysis buffer containing protease inhibitor cocktail (50 mM Hepes (pH 7.4), 
0.1% Triton X-100, 4mM EGTA, 10mM EDTA, 15 mM Na4P2O7•H2O, 100 mM 
glycerophosphate with a protease inhibitor cocktail - complete mini EDTA-free (Roche, 
Indianapolis, IN)).  Protein concentration was determined with a commercially available 
bicinchoninic acid protein assay (Pierce, Rockford, IL) to normalize each sample to 30 
µg of total protein.  Proteins were separated on 7.5% SDS-PAGE gels, transferred onto 
PVDF membranes (Immobilon-P, Millipore, Billericka, MA) blocked in 5% NFDM for 
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30 min and exposed to primary antibodies (all from Cell Signaling, Danvers, MA) 
overnight at 4ºC as follows:  phosphorylated p38 MAPK (Thr180/Tyr182, 9211, 1:500), 
total p38 MAPK (9212, 1:500), phosphorylated Erk1/2 (p44 ERK1/ p42 ERK2, 
Thr202/Tyr204, 9101, 1:1000), total Erk1/2 (9102, 1:1000) and GAPDH (14C10 Rabbit 
mAb # 2118 1: 1000).  For total protein isoforms and GAPDH analyses, phosphorylated 
immunoblots were stripped and re-probed with the above antibodies.  Products were 
visualized using enhanced chemiluminescence (ECL) on the Gene Gnome (Syngene Bio 
Imaging, Frederick, MD).  Band intensities were analyzed by densitometry using Image J 
software (NIH, Bethesda, MD) (181). 
In Vitro study – Myoblasts (C2C12, ATCC CRL-1772, Manassas, VA) were 
seeded onto 6-well plates (Greiner bio-one 657 160, Frickenhausen, Germany) and 
cultured in growth media (10% FBS (Gibco 10082-189, Carlsbad, CA), 1% penicillin and 
streptomycin (Invitrogen 15070-063, 5,000 units penicillin 5,000µg streptomycin, 
Carlsbad, CA) in DMEM, (ATCC 30-2002, Manassas, VA) for 48hrs before being 
switched to differentiation media which contained 2% Horse serum (ATCC 30-2040, 
Manassas, VA) and 1% Penicillin and Streptomycin in DMEM for 72hrs.  After cells 
were confirmed to be differentiated (visual confirmation of myotube formation, data not 
shown) myotubes were treated for various time periods with calcium ionophore (Sigma-
Aldrich, C7522 in ethanol, St. Louis, MO) or in combination with a pharmacological 
inhibitor of p38 MAPK (this inhibitor binds to the ATP binding pocket and does not 
directly affect phosphorylation status of p38 MAPK at Thr180-X-Tyr182; SB-202190, 
Sigma S7067 in DMSO, St. Louis, MO).  Gene expression and immunoblotting were 
performed as above. 
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Statistics - Gene expression targets were normalized to the reference gene Gapdh 
and then expressed relative to the baseline group.  Gapdh was not different between 
groups and thus was a sufficient loading control and normalization gene (data not 
shown).  GAPDH was also used as a loading control for protein analysis.  All values are 
presented as means ± standard error of the mean. One-way analysis of variance 
(ANOVA) was performed with significance accepted at p ≤ 0.05.   
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Results   
In vivo gene expression results 
Plantaris (PLT) - We measured Trf1, Trf2, Pot1a, and Pot1b in PLT at baseline 
(BL), TP1 and TP2.  Compared to BL, Trf1 gene expression was significantly decreased 
at TP1 (p = 0.02).  BL and TP2 Trf1 gene expression tended to be different (p = 0.07), 
while TP1 and TP2 Trf1 gene expression was similar (p = 0.58; Figure 4.1a).  Trf2 gene 
expression tended to decrease at TP1 compared to BL (p = 0.1) but was not different 
between any other groups (Figure 4.1b).  Pot1a and Po1tb gene expression were not 
different from BL at either time-point (Figure 4.1c and 4.1d, respectively).      
Tibialis Anterior (TA) – No significant changes in gene expression were observed 
for shelterin components Trf1, Pot1a, or Pot1b (Figure 4.2a, c, and d, respectively) in the 
TA.  Gene expression of Trf2 in TP1 animals was significantly higher compared to TP2 
animals (p = 0.03, Figure 4.2b) and tended to be higher than BL animals (p = 0.08) but 
was similar between TP2 and BL animals (p = 0.8).    
In vivo MAPK results 
Plantaris - Phosphorylated levels of ERK1 and ERK2 were not different between 
any groups (p = 0.5 and p = 0.8, Figure 4.3a, respectively).  Phosphorylated levels of p38 
MAPK were significantly different between BL and TP1 animals (50%, p = 0.03) but 
were not different between BL and TP2 (p = 0.3) or TP2 and TP1 (p = 0.2; Figure 4.3b).  
Tibialis Anterior – Since the response of shelterin gene expression to acute 
exercise was different between PLT and TA we wanted to investigate if MAPK 
activation was also different.  In the TA, phosphorylated levels of ERK1 were not 
different between any time-points; however, phosphorylated levels of ERK2 were 
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significantly higher in TP1 animals compared to TP2 (110% p = 0.04) and tended to be 
greater than BL animals (100% p = 0.08, Figure 4a).  No differences were detected 
between BL and TP2.  No differences were observed in the phosphorylation status of p38 
MAPK for any time-point (Figure 4.4b).  
In vitro results -   
We followed up on the down-regulation of Trf1 because of its critical importance 
in telomere length regulation and homeostasis (74,185).  Previous experiments have 
indicated that p38 MAPK activation is induced by increased calcium levels in the skeletal 
muscle cell (206) and activated p38 MAPK can influence telomere biology by altering 
the expression of shelterin components Trf1 and Trf2 (100).  We treated C2C12 myotubes 
with calcium ionophore (A23187) to induce increases in intracellular calcium levels as 
previously described (207-211) and then determined Trf1 gene expression.  Treatment 
with 1µM A23187 has been related to a ~ 4-fold increase in cytosol calcium levels in 
skeletal muscle myotubes (212).  Treatment with A23187 resulted in a significant 
decrease in Trf1 gene expression (p = 0.003, Figure 4.5) and significant increases in p38 
MAPK phosphorylation, which returned to near baseline levels 24 hrs post treatment (p = 
0.02, Figure 4.6).  To determine if p38 MAPK levels were directly related to Trf1 gene 
expression, we inhibited p38 MAPK activity with SB202190 as previously described 
(32,213). Treatment of the C2C12 myotubes with A23187 resulted in a significant 
decrease in Trf1 gene expression, which was completely prevented by inhibition of p38 
MAPK with SB202190 (p < 0.001, Figure 4.7).  
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Discussion   
 We demonstrate for the first time that acute endurance exercise alters gene 
expression of Trf1 in mouse skeletal muscle and also show potential link Trf1 expression 
and p38 MAPK activation.  TRF1 plays a critical protective role in the maintenance of 
telomere length, thus these data provide important insights into a possible mechanism for 
the paradoxical loss of telomere length induced by chronic exercise in skeletal muscle.  
Understanding how chronic endurance exercise results in telomere shortening will 
provide further insights into the complex regulation of telomere dynamics in skeletal 
muscle and perhaps other post-mitotic tissues. 
Several groups, including our own, have recently shown that exercise training 
slows age-related telomere shortening in several tissues, with the important exception of 
skeletal muscle ((5,8,9,130) and Ludlow et al. under review).  In skeletal muscle, 
multiple groups have demonstrated a loss of telomere length with chronic exercise 
((7,109) and Ludlow et al. under review).  In our previous study, we found that chronic 
voluntary exercise (1 yr) attenuated an aging-induced increase in mouse skeletal muscle 
Trf1 protein content suggesting that exercise may negatively regulate Trf1.  Those results 
suggested a unique regulation of the telomere complex in skeletal muscle in response to 
chronic exercise when compared to other tissues (Ludlow et al. under review).  For 
example, in cardiac tissue Werner et al. (9) found that wheel running for 21 days in mice 
resulted in increased Trf1 gene expression compared to sedentary mice, which further 
indicates that regulation of telomere biology is different in skeletal muscle.  To the best 
of our knowledge, only one other study has investigated Trf1 gene expression in skeletal 
muscle; in Duchenne’s muscular dystrophy patients compared to controls, Trf1 gene 
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expression was increased (along with shorter telomeres) (214).  These intriguing findings 
led us to examine the role of acute exercise as a means to identify potential signals that 
may alter Trf1 gene expression in skeletal muscle.   
Numerous cellular signaling pathways are activated by contraction of skeletal 
muscle, including the MAPK pathway (171). Due to the unique telomere response 
observed in exercised skeletal muscle, we hypothesized that this shortening may be a 
stress response induced by the exercise.  Thus, we targeted the MAPK signaling pathway 
since numerous studies have shown that components of this family are induced by 
external stresses and exercise in particular.  Indeed, we observed that our treadmill 
paradigm resulted in enhanced phosphorylation of p38 MAPK in the PLT muscle, though 
we found no response in the TA muscle.  The activation of p38 MAPK occurs during 
muscle contraction and the amount of activation is dependent on the type, time, and 
intensity of the contractions (149).  Treadmill running in rodents recruits the PLT to 
contract to a greater extent than the TA (182,215), which likely explains the measureable 
p38 MAPK phosphorylation in the PLT but not the TA.  Thus, in the muscles where Trf1 
mRNA expression was reduced we found increased phosphorylation of p38 MAPK.   
Previous, in vitro studies have found that elevations in intracellular calcium levels 
can activate p38 MAPK (166,206), which is an effect known to happen in skeletal muscle 
during and after a bout of exercise (216).  Thus, elevations in intracellular calcium may 
act as an upstream signal resulting in reduced Trf1 mRNA expression.  Using previously 
described methods (207), we exposed cultured C2C12 myotubes to A21387 to increase 
intracellular calcium (212), which resulted in significant increases in p38 MAPK 
phosphorylation.  Similar to our in vivo results, we found that when p38 MAPK was 
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phosphorylated there was a subsequent decrease in Trf1 mRNA content.  To determine if 
p38 MAPK was a critical mediator of the calcium effect, we inhibited p38 MAPK using 
SB202190 in combination with A21387 and prevented the reduction in Trf1 gene 
expression.  These data indicate a link between p38 MAPK signaling and Trf1 gene 
expression and support our in vivo observations that p38 MAPK activation may be 
regulating the reduced Trf1 gene expression.  We are aware of few data demonstrating 
this linkage between p38 MAPK and Trf1 with the exception of Spallarossa et al. (100) 
who observed decreased Trf1 gene expression when treating cardiomyocytes with 
doxorubicin, which resulted in a simultaneous increase in phosphorylation of p38 MAPK.  
Our results provide a rationale for future experiments to test possible mechanisms by 
which long-term aerobic exercise training results in shortened telomeres in skeletal 
muscle.   
Our data indicate that contraction/exercise-dependent decreases in Trf1 gene 
expression may be the result of p38 MAPK activation.  We speculate that intracellular 
elevations in calcium may be an important signal in this activation, though it is equally 
possible that other signals could also activate p38 MAPK during exercise (e.g., reactive 
oxygen species).  We hypothesize that repeated bouts of unaccustomed exercise could 
result in transient decreases in mRNA expression of Trf1, which ultimately result in 
reduced TRF1 protein content (Figure 4.8).  This situation of reduced TRF1 protein could 
lead to altered telomere length homeostasis and over time a loss of telomere length in 
exercise-trained skeletal muscles (i.e., repeated exposure to contractions).  With long-
term training the response of p38 MAPK would diminish and result in a return of basal 
expression of Trf1, though telomere length loss may have already occurred due to the 
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initial response of Trf1 to repeated bouts of exercise.  Our previous study indicated that 
after chronic (1 yr) exercise training Trf1 expression was similar to that of young 
animals, but that sedentary animals had elevated Trf1 (Ludlow et al. under review).  In 
combination with the present findings, these results indicate that repeated bouts of 
exercise would result in decreased Trf1, which over time could lead to telomere 
shortening in chronically active individuals, suggesting unique regulation of mouse 
skeletal muscle Trf1 in response to acute exercise. 
In summary, we show that the reduced gene expression of Trf1 in response to 
acute exercise is in part regulated by contractile activation of p38 MAPK in skeletal 
muscle.  These results represent a first step in understanding the mechanism behind how 
skeletal muscle telomere length is reduced in chronically-trained rodents or humans.  We 
provide insight into how unaccustomed exercise may initially result in loss of telomere 
protection (i.e., down regulation of Trf1) and thus lead to unrepaired telomere DNA 
damage and telomere length loss.  Future studies are needed to determine the timeline of 
reduced Trf1 gene expression in response to exercise training and also the timing and 
mechanism of telomere shortening in skeletal muscle in response to chronic (repeated 
acute bouts) of exercise.  
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Supplemental Table 4.1.  
Supp. Table 
4.1. 
Treadmill acclimation procedures. 
Session Time (min) Belt speed 
(m*min-1) 
Shock pad  Days 
1 0 - 5 0 No shock 1-2 
5 -15 2 No shock  
2 0 - 2 0 No shock 4-5 
2 - 5 2 No shock  
5 - 10 5 Light   
10 - 15 10 Light  
3 0 - 2 0 No shock 7-8 
2 - 5 5 Light  
5 - 10 15 Light  
10 - 15 20 Moderate  
4* 0 - 2 0 No shock 10-11 
2 - 5 5 Light  
5 - 10 15 Moderate 13-14 
10 - 15 20 – 24 High  
Supplemental Table 4.1 shows the treadmill acclimation procedures. Light shock (1.02 
mA; 2.7 pulses*sec-1); Moderate shock (2.04 mA; 2.7 pulses*sec-1); High shock (3.06 
mA; 2.7 pulses*sec-1).  Intensity in milliamperes (0.34 to 3.4mA) and repetition rate at 
200msec pulses at a rate of 0.3 to 3 pulses per second.  * Session 4 was repeated twice. 
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Figure 4.1.  Acute exercise reduced shelterin component gene expression in the 
plantaris.  Trf1 gene expression was significantly reduced in TP1 animals compared to 
BL animals (p = 0.02), tended to remain reduced at TP2 (p = 0.07) and was not different 
between TP1 and TP2 (p = 0.58).  Trf2 mRNA expression tended to decrease in TP1 
animals compared to BL (p = 0.1) but was not different between BL and TP2 (p = 0.3, 
Figure 1b) or between TP1 and TP2 (p = 0.5).  Pot1a and Po1tb mRNA expression was 
not different between any groups (p = 0.3 and p = 0.4, Figure 1c and 1d, respectively).  
Data are presented as means ± S.E.M.  mRNA abundance was assessed with RT–PCR, 
corrected for Gapdh and expressed relative to the BL group.  BL = baseline (n = 6).  TP1 
= time-point 1 (n = 8) animals sacrificed immediately following the exercise bout.  TP2 = 
time-point 2 (n = 8) animals sacrificed 1hr following the exercise bout.  *TP1 
significantly different than BL (p < 0.05).  Ŧtendency for TP2 to be different than BL (p < 
0.1).  §tendency for TP1 to be different than BL (p < 0.1). 
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Figure 4.2. Gene expression of shelterin components in tibialis anterior muscle 
following acute exercise. Trf1 gene expression was not different in TP1 or TP2 animals 
compared to BL animals (p = 0.3, p = 0.7, respectively) and were not different between 
TP1 and TP2 (p = 0.1, Figure 2a).  Trf2 gene expression was higher in TP1 compared to 
TP2 animals and tended to be higher than BL (p = 0.03, p = 0.08, respectively) but were 
similar between BL and TP2 (p = 0.8, Figure 2b). Pot1a and Po1tb mRNA expression 
were not different between any groups (p = 0.2 and p = 0.2, Figure 2c and 2d, 
respectively).  Data are presented as means ± S.E.M.  mRNA abundance was assessed 
with RT-PCR, corrected for Gapdh and expressed relative to the BL group. BL = baseline 
(n = 6).  TP1 = time-point 1 (n = 8) animals sacrificed immediately following the exercise 
bout.  TP2 = time-point 2 (n = 8) animals sacrificed 1hr following the exercise bout.  #TP 
1 significantly different than TP2 (p < 0.05).  §tendency for TP1 to be different than BL 
(p < 0.1). 
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Figure 4.3.  p38 MAPK is activated following acute treadmill exercise in the 
plantaris.  We measured the phosphorylation status of the MAPKs ERK1/2 and p38 
following acute treadmill exercise.  ERK1/2 was not different among any groups (ERK1 
p44 p = 0.6) and (ERK2 p 42 p = 0.8).  p38 MAPK had significantly increased 
phosphorylation at TP1 compared to BL (p = 0.03), TP1 and TP2 were similar (p = 0.2) 
as were BL and TP2 (p = 0.3).  Densitometric analysis and representative immunoblot 
images are shown. Data are presented as means ± S.E.M. Phosphorylated to total protein 
content ratios were derived and then expressed relative to the BL group for comparisons. 
GAPDH was a loading reference.  BL = baseline (n = 6).  TP1 = time-point 1 (n = 8) 
animals sacrificed immediately following the exercise bout.  TP2 = time-point 2 (n = 8) 
animals sacrificed 1hr following the exercise bout.  *TP1 significantly different than BL 
(p < 0.05).   
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Figure 4.4.  p38 MAPK is not activated following acute treadmill exercise in the 
tibialis anterior.  ERK1 (p44) phosphorylation was not significantly altered in the TA 
due to treadmill exercise (p = 0.4). ERK2 (p42) phosphorylation was greater at TP1 
compared to TP2 (p = 0.04), and tended to be greater than BL (p = 0.08), but BL and TP2 
were similar (p = 0.8).  p38 MAPK phosphorylation was not significantly altered by 
treadmill exercise (p = 0.6).  Densitomeric analysis and representative immunoblot 
images are shown. Data are presented as means ± S.E.M. Phosphorylated to total protein 
content ratios were derived and then expressed relative to the BL group for comparisons. 
GAPDH was a loading reference.  BL = baseline (n = 6).  TP1 = time-point 1 (n = 8) 
animals sacrificed immediately following the exercise bout.  TP2 = time-point 2 (n = 8) 
animals sacrificed 1hr following the exercise bout.  #significantly different than TP2 (p < 
0.05).  §tendency for TP1 to be different than BL (p < 0.1). 
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Figure 4.5. Calcium ionophore stimulation in C2C12 myotubes results in down-
regulation of Trf1 gene expression.  Myotubes after 72hrs of differentiation were 
treated with calcium ionophore (A23187, 1µM) for 24hrs to induce a similar reduction in 
Trf1 gene expression as observed in vivo following treadmill running.  All experiments 
were performed in duplicate on at least 3 separate occasions, in serial passage.  Data are 
presented as means ± S.E.M.  mRNA abundance of Trf1 and Gapdh were assessed with 
RT-PCR, corrected for Gapdh and expressed relative to the BL group. *A23187 treated 
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Figure 4.6. Calcium ionophore stimulation results in p38 MAPK phosphorylation in 
C2C12 myotubes.  To determine if calcium ionophore treatment resulted in 
activation/phosphorylation of p38 MAPK myotubes were treated for 3hrs with 1µM 
A23187 or control and protein was isolated 30min and 24hrs following treatment.  
Calcium ionophore treatment resulted in significant phosphorylation of p38 MAPK 
compared to BL. Densitometric analysis and representative immunoblot images are 
shown.  Data are presented as means ± S.E.M.  Phosphorylated to total protein content 
ratios were derived and then expressed relative to the BL group for comparisons. 
GAPDH was a loading reference.  BL = vehicle treated. A23187 = treated for 3hrs, and 
protein isolated 30min post treatment.  24H post = myotubes treated for 3hrs, and protein 
isolated 24hrs post-treatment.  All experiments were performed in duplicate on at least 3 
separate occasions, in serial passage. *A23187 significantly different than BL (p < 0.05).  
#A23187 significantly different than 24H post (p < 0.05). 
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Figure 4.7.  Inhibition of p38 MAPK prevents reduction of Trf1 gene expression.  To 
determine if p38 MAPK activation was directly related to Trf1 gene expression, we 
treated myotubes with calcium ionophore and in combination with p38 MAPK inhibitor 
SB 202190 (note – this inhibitor does not affect phosphorylation at Thr180-X-Tyr182 but 
inhibits p38 activity by competitively binding to the ATP binding site).  Myotubes were 
treated with control (vehicle), calcium ionophore (A23871, 1µM) or pretreated with SB – 
202190 p38 MAPK inhibitor (10µM) for 30min prior to 24 hrs of treatment with A23187.  
Treatment with p38 MAPK inhibitor prevented the calcium ionophore-induced decrease 
in Trf1 gene expression.  All experiments were performed in duplicate on at least 3 
separate occasions, in serial passage.  Data are presented as means ± S.E.M.  mRNA 
abundance of Trf1 and Gapdh were assessed with RT-PCR, corrected for Gapdh and 
expressed relative to the BL group. BL = vehicle treated (DMSO and EtOH).  A23187 = 
ionophore treated. Sb 202190 = myotubes treated in combination with A23187 and p 38 
MAPK inhibitor. *A23187 significantly different than BL.  #A23187 significantly 
different than Sb 202190. 
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Figure 4.8.  Proposed molecular mechanism of altered skeletal muscle Trf1 gene 
expression following acute exercise.  Our data indicate that Trf1 gene expression in 
skeletal muscle is activity dependent and mediated by p38 MAPK. We propose that 
skeletal muscle contraction-induced calcium transients activate kinases (such as CAMK 
II) that phosphorylate and activate p38 MAPK resulting in altered activity of unidentifed 
transcription factors that control Trf1 gene expression, leading to reduced levels of Trf1 
expression. Repeated acute exercise bouts would then be expected be related to telomere 
shortening as a result of chronic reductions in TRF1 protein.  
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Chapter 5: Adult skeletal muscle fiber telomere dynamics following oxidative stress 
treatment:  A comparison between short (CAST) and long (C57BL/6) telomere 
strains of mice. 
The following is a manuscript in preparation based on my final dissertation work.   
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Abstract   
 
In most cells telomeres shorten over time due to a combination of incomplete replication, 
end processing, and unrepaired damage, thus making telomere length a biomarker of 
aging.  Skeletal muscle telomere length, however, does not change with age due to its 
post-mitotic state.  Paradoxically, chronic endurance exercise training, which slows 
telomere attrition in most tissues, is associated with shorter skeletal muscle telomere 
length.  Since telomeres shorten due to unrepaired oxidative damage in other tissues, we 
sought to determine if oxidative stress shortens telomeres in isolated adult skeletal muscle 
fibers.  Flexor digitorum brevis muscles were dissected from 15 male C57BL/6 (long 
telomere) and 20 male CAST/Ei (wild-derived, short telomere) mice and dissociated into 
single fibers.  Fibers were cultured for 5 days in control, hydrogen peroxide (oxidant), or 
a combination of N–acetylcysteine (antioxidant) and hydrogen peroxide.  Telomere 
length, telomerase enzyme activity, and protein content of TRF1 and TRF2 (important for 
telomere protection) were determined.  In both strains, oxidative stress resulted in 
significant telomere shortening in isolated skeletal muscle fibers.  Telomerase enzyme 
activity was not altered by oxidative stress treatment but was different between strains, 
with greater telomerase activity in long-telomere C57BL/6 mice (p < 0.01).  TRF1 
protein content was increased in CAST/Ei fibers that were exposed to the combination of 
oxidant and antioxidant.  In oxidant-treated C57BL/6 fibers TRF2 protein content was 
increased compared to control fibers but this was attenuated in the presence of 
antioxidant.  The response of TRF1 and TRF2 to oxidative stress exposure seems to be 
dependent on basal telomere length, long-telomere mice responding by expressing TRF2 
and short telomere mice by expressing TRF1.  These results provide important insights 
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into a mechanism by which chronic endurance exercise could shorten skeletal muscle 
telomeres.  
 
Keywords:  telomere length, telomere binding proteins, wild-derived mice, DNA 
damage   
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Introduction  
 
Telomeres are repetitive DNA sequences (5’-TTAGGGN-3’) at the ends of linear 
chromosomes (61).  In most tissues telomeres shorten over time due to a combination of 
incomplete replication, chromosome end processing, and unrepaired telomere DNA 
damage (103,197).  Adequate telomere length is important in maintaining genome 
stability and regulating transcription (201,217).  The enzyme telomerase can maintain 
and lengthen telomeres in germline, stem, and other highly proliferative cells 
(63,188,200,218).  Telomere shortening has thus been studied as a biomarker of aging 
and is implicated in cancers and other age-related diseases such as cardiovascular disease 
(160,219). A variety of environmental factors important to age-related disease have been 
studied as modifiers of age-related telomere shortening.  Among these, chronic exercise 
has emerged as a protective stimulus for a variety of cell types, attenuating age-related 
telomere shortening in heart, vascular tissue and lymphocytes (5,8,9,130). 
Contrary to most tissues, telomere length does not change with age in skeletal 
muscle, likely stemming from its post-mitotic status and low cell turnover (Ludlow et al. 
under review, (107,191,192,220,221)).  Paradoxically, skeletal muscle telomere length 
from long-term exercise trained individuals is shorter than telomere length of sedentary 
or young individuals (Ludlow et al. under review, (7,109)).  These findings indicate a 
contradictory situation where shortened telomere length, typically considered a negative 
cellular phenotype, is occurring concurrently with the many positive health benefits of 
chronic exercise in skeletal muscle, such as increased insulin sensitivity, improved 
mitochondrial content, and increased antioxidant enzyme capacity (196).  
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Literature about the mechanism(s) of how skeletal muscle telomeres respond to 
chronic exercise is lacking.  Skeletal muscle is extremely sensitive to oxidative DNA 
damage because of low antioxidant capacity compared to other tissues and deficiency in 
DNA repair enzymes (44).  Skeletal muscle-derived reactive oxygen species (ROS) 
arising during contractions (162) may be a mechanism of damage to telomeres.  
Telomeres, particularly the 5’-GGG triplet, are extremely sensitive to oxidative DNA 
damage (45,193) and are also refractory to repair (47).  Unrepaired DNA damage in the 
telomere can result in non-replication-based telomere shortening (193).   
In addition to telomerase, a six-protein complex termed shelterin regulates 
telomere length (79,173,222) by acting to protect chromosome ends from being 
recognized by DNA damage machinery, maintaining telomere loop (T-loop) structure, 
and regulating telomerase action at the telomere (73,223).  Core shelterin components 
telomere-repeat binding factor 1 and 2 (TRF1 and TRF2) are critical regulators of 
telomere length homeostasis and end-protection (74,173,185).  TRF1 is a regulator of 
telomere length and important in cell cycle progression (224), while TRF2 is critical in 
DNA damage response, telomere length regulation and prevention of end-to-end fusions 
(173).  These proteins are thus critical in the response to telomere DNA damage agents 
(i.e., oxidative stress) and may play an important role in telomere length regulation in 
skeletal muscle in response to acute exercise.  
In the present study we sought to determine a possible mechanism whereby 
chronic exercise could result in telomere shortening in post-mitotic skeletal muscle.  To 
do this we cultured isolated adult skeletal muscle fibers to eliminate contaminating cell 
types (e.g., satellite cells, vascular tissue, etc.), which allowed us to isolate the effect of 
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oxidative damage directly on skeletal muscle telomeres.  In addition, we performed these 
experiments in two strains of mice with naturally differing telomere lengths in order to 
complete the following three aims: 1) to determine how telomere length in skeletal 
muscle is affected by oxidant exposure; 2) to determine the effect of oxidative stress on 
telomerase enzyme activity; and 3) to determine the effect of oxidative stress on telomere 
binding protein content (i.e., TRF1 and TRF2).  We hypothesized that oxidative stress 
would decrease skeletal muscle telomere length and increase the protein content of 
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Methods  
 
Animals - All animal experiments were approved by the University of Maryland 
Institutional Animal Care and Use Committee and conformed to the National Institutes of 
Health’s Guide for the Use and Care of Laboratory Animals (NIH Pub. No. 85-23, 
revised 1996).  Twenty male CAST/Ei (Mus Musculus Castaneus, 7-9 wk old) and fifteen 
male C57BL/6 (Mus Musculus, 8-10wk old) mice were purchased (Jackson Laboratory, 
Bar Harbor, ME).  Animals were acclimated to the animal facility for at least 2 days prior 
to being randomly assigned to treatment groups.  The animals were housed at 25ºC on a 
12 hour light-dark cycle.  Animals were fed ad libitum laboratory mouse chow (Prolab 
RMH 3000, 5P00, LabDiet, Nestle Purina, Vevey, Switzerland) and given free access to 
water.  The animals were anesthetized (3% isoflurane) and euthanized by heart excision. 
Single muscle fiber isolation procedure – Flexor digitorum brevis (FDB) skeletal 
muscles were dissected with a stereoscope (AmScope, Trinocular Stereo 3.5X-90X 
model SM-2TZ, Irvine, CA) in a sterile phosphate buffered saline solution (pH. 7.4, room 
temperature).  Following dissection and removal of excess connective tissue, muscles 
were placed in 2mL of dissociation media (10% Fetal bovine serum (FBS, Gibco 10082-
189, Carlsbad, CA), 1% Pennstrep (PS, Invitrogen 15070-063, 5,000 units penicillin 
5,000µg streptomycin, Carlsbad, CA), (MEM, Gibco, 11095-080, Carlsbad, CA) with 
Liberase TM®, (13 Wunsch Units/mL, a blend of type I and II collagenases, Roche, 05 
401 119 001, Indianapolis, IN) in a 35mm culture dish and placed in a cell culture 
incubator for 90 min (37ºC, 5% CO2, ambient air).  After the 90 min incubation, FDB 
muscles were rinsed of excess collagenase by a series of three one-minute washes in 
35mm dishes containing pre-warmed MEM supplemented with 1% PS.  The muscle was 
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then placed into a single well of a six-well culture plate (Greiner bio-one Cell Star®, 657 
160, Frickenhausen, Germany) with 2 mL of MEM supplemented with 1% PS and gently 
titrated with 10-15 strokes with a 1 mL pipette or until the muscle was visibly dissociated 
(10x inverted microscope inspection).  To reduce the incidence of muscle fiber 
dedifferentiation and myoblast/fibroblast proliferation, FBS was not used in the final 
culture media (225). 
Cell culture and fiber treatments  - After fibers from all animals were completely 
dissociated, 6-well plates were placed into an airtight cell culture chamber (Supplemental 
Figure 5.1).  The chamber was then flushed with a gas mixture for 5 min at 2 p.s.i. (2% 
oxygen, 5% carbon dioxide and 93% nitrogen) designed to replace the ambient oxygen 
level (21%) with a physiological oxygen level (~2-5% as previously described (226)) and 
allowed to rest overnight in the 37ºC cell culture incubator. The following day the fibers 
were inspected and treated with randomly assigned culture conditions (control = MEM, 
1% PS; H2O2 = 1µM H2O2 (maximum dose tolerable for duration of treatment, see 
Supplement Figure 5.2, (165)), Sigma A8199; NAC+ = 1µM H2O2 plus 100µM N-
acetylcysteine, St. Louis, MO) for five days.  Treatment with 1µM H2O2 has been shown 
to induce intracellular concentrations of ~0.1µM in skeletal muscle fibers which is 
similar to the amount of ROS produced by electrically-stimulated contraction of FDB 
fibers (165).  Thus this dose of hydrogen peroxide treatment likely represents a 
physiologically relevant dose of ROS in skeletal muscle fibers.  Previous observations 
(Ludlow et al. unpublished obs.; Study #3; (227)) indicated that telomeric responses may 
accumulate over time (i.e., repeat exposure effect) and lead to telomere shortening, thus 
we treated our fibers for 5 days rather than with a single dose. 
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The two FDBs from each animal were placed into separate wells of a 6-well plate 
and treated identically, thus each treatment group consisted of fibers from at least 5 
animals (exact sample sizes reported in results).  Treatments were replaced and the 
chamber re-flushed with low oxygen gas mixture every 24hrs.  After five days of 
treatment ~800 fibers per animal were removed via inspection with a stereoscope and 
200µL pipette and placed into four individual microcentrifuge tubes (~200 fibers/tube) 
for processing.  Data were collected from C57BL/6: ~200 fibers from different five 
animals per treatment.  CAST/Ei: ~200 fibers from 6-7 animals per treatment.  Collected 
skeletal muscle fibers from C57BL/6 or CAST/Ei mice were centrifuged (17,000 x G, 
25ºC, 5min) to pellet the fibers.  Following centrifugation the supernatant was removed 
and lysis buffers for extraction of proteins, DNA or RNA were added to the pelleted 
fibers and frozen at -80ºC until further analysis (details below).  These procedures were 
repeated for each strain of mice.  
Telomere length – DNA was isolated from ~200 fibers and quantified as 
previously described ((130), Ludlow et al. under review).  Between 12.5 and 20 ng of 
total genomic DNA was added to a reaction mixture as previously described (Ludlow et 
al. under review).  All samples were run in triplicate, with a standard curve and reference 
samples were run on both plates to ensure linearity.  The reference samples were from a 
previous study of CAST / Ei mice that had telomere length determined via telomere 
restriction fragment analysis (TRF southern blotting technique) (Ludlow et al. under 
review) to ensure accuracy of the assay.   
Telomerase - Fibers were thawed at 4ºC, briefly centrifuged in a bench-top 
centrifuge, supernatant removed and 200µL of quantitative telomerase lysis buffer 
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(Quantitative Telomerase Detection Kit; US Biomax, Rockville, MD) was added to the 
pelleted fibers.  Samples were then placed on ice with intermittent vortex mixing (every 
15min) for 1hr followed by centrifugation (12,000 x g, 4ºC for 30min).  Following 
centrifugation, supernatants were removed and assayed for protein content using a 
bicinchoninic acid protein assay (Pierce, Rockford, IL).  In addition, cells from a 
telomerase positive human cancer cell line were treated as above and included as a 
positive control (HeLa, ATCC CCL-2, Manassas, VA).  For unknowns and HeLa control 
samples 1µg of extracted protein was added to the reaction mixture according to the 
recommendations of the manufacturer and as previously performed in our lab (Ludlow et 
al. 2008). Telomerase activity was determined using a commercially available kit 
utilizing the telomere repeat amplification protocol (TRAP; Quantitative Telomerase 
Detection Kit; US Biomax, Rockville, MD).  Beyond the kit-provided standards, heat-
treated samples were assayed as negative controls.  Heat-treated samples were concluded 
to be telomerase negative if the mean of the critical threshold (Ct) for the heat-treated 
sample duplicates was three standard deviations above that of the telomerase positive 
sample.  Telomerase analysis was done as previously described by our lab ((130), 
Ludlow et al. under review). 
Immunoblotting – Prior to freezing, fibers were lysed in 300µL of lysis buffer 
(100 mmol/ l Tris [pH 6.8], 4% sodium dodecyl sulfate [SDS], 20% glycerol and protease 
inhibitor cocktail (complete mini EDTA-free, Roche, Indianapolis, IN).  Fibers were 
thawed on ice for 1hr and assayed for protein content as above.  Fifty (TRF2 and 
GAPDH) and 90µg (TRF1 and GAPDH) samples were prepared for immunoblotting.  
Proteins were resolved on 10% SDS-PAGE gels, transferred to PVDF membranes and 
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blocked for 30min in 5% NFDM and exposed to primary antibodies overnight at 4ºC as 
follows: TRF1 (C-19, SC 1977, 1:200, Santa Cruz Biotechnologies, Santa Cruz, CA), 
TRF2 (H-300, SC 9143, 1:200, Santa Cruz Biotechnologies, Santa Cruz, CA) and 
GAPDH (Cell signaling, 14C10 Rabbit mAb # 2118 1: 1000, Beverly, MA).  All 
products were visualized with horseradish peroxidase-linked secondary antibodies using 
high sensitivity enhanced chemiluminescence (SuperSignal West Dura 
Chemiluminescent Substrate, Pierce, Rockford, IL) on the Gene Gnome (Syngene Bio 
Imaging, Fredrick, MD).  Band intensities were analyzed by densitometry using Image J 
software (NIH, Bethesda, MD) (181). 
Statistical analysis - All values, unless otherwise stated, are presented as means ± 
standard error of the mean.  Generalized linear models were used to analyze the data with 
SAS version 9.2.  We collapsed all treatment groups and compared absolute values of 
each strain to assess strain differences.  Treatment effects for each strain were determined 
with one-way ANOVA.  A priori contrasts were analyzed with one-tailed t-tests. 
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Results   
 
Single muscle fiber morphology is not altered at physiological oxygen tension.   In an 
attempt to culture skeletal muscle fibers at or near physiological conditions (PO2 in 
resting skeletal muscle is ~6-7 Torr or ~1%), we reduced the oxygen levels to 2-5% in an 
airtight cell culture chamber (Supplemental Figure 5.1) (228,229).  Since oxygen levels 
of cultured murine cells are related to increased DNA damage, reducing the exposure of 
the skeletal muscle fibers to oxygen allowed us to more accurately assess the effects of 
our oxidant exposure (230).  No noticeable differences in single muscle fiber morphology 
between strains or among treatment groups were observed in the cultures (Figure 5.1).  In 
addition, we did not observe any fiber dedifferentiation (i.e., nuclei blebbing) or 
myoblast/fibroblast integration into single muscle fibers in any strain or treatment group.    
 
Telomere Length is reduced in H2O2 treated adult single muscle fibers.  Isolated 
single fibers from both strains were treated with control (CONT; C57BL/6 n = 5, 
CAST/Ei n = 7), hydrogen peroxide (H2O2; C57BL/6 n = 5, CAST/Ei n = 6) or a 
combination of H2O2 and the antioxidant N-acetylcysteine (NAC, combination treatment 
NAC+; C57BL/6 n = 5, CAST/Ei n = 6), as previously described (165). Hydrogen 
peroxide treated fibers from C57BL/6 mice tended to have shorter telomeres compared to 
control treated fibers (p = 0.08), shortening that was significantly attenuated by treatment 
with the antioxidant NAC (H2O2 vs. NAC+, p = 0.05; Figure 5.2), indicating a causal role 
of oxidative stress in telomere shortening.  In CAST/Ei mice, H2O2 resulted in significant 
telomere shortening compared to control (p = 0.04; Figure 5.2); however, antioxidant 
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treatment did not result in attenuation of telomere shortening (H2O2 vs. NAC+, p = 0.4; 
Figure 5.2) and tended to be shorter than control (p = 0.07; Figure 5.2). 
 
Telomerase enzyme activity was not altered by oxidant treatment in muscle fibers. 
As shown in Figure 5.3, H2O2 treatment did not result in any significant change in 
telomerase enzyme activity in either strain of mice (C57BL/6 p = 0.8; CAST/Ei p = 0.6), 
nor did the addition of NAC impact telomerase activity in either strain (C57BL/6 p = 0.8; 
CAST/Ei p = 0.6).  
 
Oxidative stress treatment resulted in altered protein content of TRF1 and TRF2.  
TRF1: In C57BL/6 fibers, no differences in protein content of TRF1 between 
H2O2 or NAC+ treatments were observed (p = 0.9; Figure 5.4).  In the CAST/Ei fibers, 
no differences in TRF1 protein content were observed between control and H2O2 (p = 
0.5; Figure 5.4); however, CAST/Ei fibers treated with a combination of NAC and H2O2 
had significantly greater TRF1 protein content than both control (p = 0.04) and H2O2-
treated fibers (p = 0.01; Figure 5.4).  
TRF2: In C57BL/6 fibers, H2O2 treatment resulted in increased protein content of 
TRF2 compared to control (p = 0.1; Figure 5.5) that was attenuated in NAC+ treated 
fibers (p = 0.05; Figure 5.5), indicating a causal role of ROS in the TRF2 response.  In 
CAST/Ei fibers, no significant alterations in TRF2 protein content were observed in 
either treatment group (Figure 5.5).  
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Strain comparisons reveal differences in telomere length and telomerase activity but 
not shelterin protein content.  To determine strain differences we compared C57BL/6 
and CAST/Ei mice regardless of treatment.  As shown in Table 5.1, typical laboratory 
mice (C57BL/6), mice had longer telomeres compared to wild-derived CAST/Ei mice, 
confirming earlier reports (p < 0.01; Figure 5.2 and Table 5.1) (60).  The C57BL/6 
telomere length was reduced 4.1 fold (76% of control) in response to H2O2 treatment 
while the CAST/Ei telomere length was reduced 2.9 fold (67% of control).  C57BL/6 
mice had significantly greater telomerase enzyme activity compared to CAST/Ei  (p < 
0.01; Figure 5.3 and Table 5.1), similar to previous findings (231).  For both TRF1 and 
TRF2 protein content, no differences were observed between strains (TRF1 p = 0.4; 
TRF2 p = 0.7; Figure 5.4 and Figure 5.5, respectively and Table 5.1).   
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Discussion  
 We demonstrate for the first time in isolated adult mouse skeletal muscle fibers 
that oxidative stress is a causative factor in telomere shortening. Oxidant treatment 
resulted in dramatic telomere shortening that was prevented with antioxidant treatment, 
most significantly in the long-telomere C57BL/6 strain.  Telomerase activity was not 
impacted by the treatments, but we describe differences in activity between typical 
laboratory (long telomere) and wild-derived (short telomere) strains of mice that impact 
interpretation.  Moreover, both TRF1 and TRF2 showed differential, strain-specific 
responses to oxidant and antioxidant treatment indicating strain-specific telomere 
dynamics in skeletal muscle. Our results indicate in C57BL/6 mice that TRF2 protein 
content is increase with ROS, possibly to prevent further telomere shortening.  In 
CAST/Ei mice neither TRF1 nor TRF2 responded to ROS treatment independently, 
indicating important strain differences in the response to ROS that may be dictated by 
differences in basal telomere length.  These results provide insights into the complex 
regulation of telomeres in post-mitotic tissues and clarify how factors (i.e., ROS) 
associated with muscle contraction and chronic endurance exercise may result in 
shortened telomeres in skeletal muscle.  
Telomere dogma states that telomeres shorten with replication or exposure to 
DNA damage signals (e.g., ROS) and over time may reach a critical length causing 
telomere and tissue dysfunction (31). While this dogma holds true for aging of most 
human somatic cells, skeletal muscle cells do not follow this pattern of age-related 
telomere attrition.  Our results and those of others have shown little to no age-related 
telomere shortening in skeletal muscle of healthy older mammals, both human and rodent 
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(Ludlow et al. under review, (191)).  Recent reports and data from our lab have, however, 
shown skeletal muscle telomere shortening in skeletal muscle homogenates from mice 
and humans that have undergone chronic exercise training (Ludlow et al. under review, 
(7,197)).  In addition, we have recently observed that a single bout of treadmill exercise 
produced a stress response that resulted in Trf1 down-regulation in skeletal muscle 
(Ludlow et al. unpublished obs. Study #3).  These data indicate that the initial response to 
acute exercise in skeletal muscle could predict long-term telomere length loss and that 
repeated exercise bouts could result in accumulated damage to the telomere.  
 Telomere length shortens in skeletal muscle under oxidative stress.  In vivo it 
is thought that telomere length in skeletal muscle only shortens when the satellite cells 
are induced to divide and incorporate into existing fibers (106), such that shorter telomere 
nuclei accumulate in the tissue over time.  Endurance exercise is not associated with 
enhanced satellite cell proliferation or incorporation into muscle fibers (106) making this 
an unlikely cause of such telomere shortening.  Instead, we show for the first time, 
similar to other tissues (85,99), that oxidative stress can cause telomere shortening in 
skeletal muscle fibers devoid of satellite cells. Interestingly, treatment with the 
antioxidant NAC attenuated telomere shortening in skeletal muscle fibers of C57BL/6 
mice but not in CAST/Ei fibers.  This could indicate that skeletal muscle fibers from 
CAST/Ei mice have inherently higher basal oxidative stress thus requiring a greater dose 
of antioxidant to overcome the additional oxidative stress burden of hydrogen peroxide 
treatment.  Alternatively, intrinsic differences in telomere length and telomere dynamics 
between the strains could underlie this differential response.  Overall, we report that ROS 
is indeed a possible mechanism for telomere shortening in adult skeletal muscle fibers of 
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both typical and wild-derived strains of mice, though the dynamics of this shortening are 
strain-specific.     
 Telomerase enzyme activity is not increased in single muscle fibers exposed 
to oxidative stress.  Previous studies have reported ambiguous results regarding 
telomerase enzyme activity following oxidative stress treatments across a range of tissues 
(67,144,232,233).  Interestingly, we report no effect of oxidant challenge on telomerase 
activity, but that telomerase activity is greater in muscle fibers of C57BL/6 compared to 
short-telomere CAST/Ei mice, supporting previous findings (231). Our results confirm 
those of Cattan et al. (64) who showed that telomerase enzyme activity was not increased 
in skeletal muscle of CAST/Ei animals exposed to oxidative stress (long-term glutathione 
depletion).  This could indicate that telomerase activity in skeletal muscle of mice is 
detectable, but extremely low compared to other tissues and therefore plays a minimal 
role in skeletal muscle fiber telomere dynamics.  
TRF protein content is altered in response to oxidative challenge but differs 
by strain.  Several recent studies have observed altered expression of TRF1 and TRF2 
induced by multiple stimuli (8,9,100,234).  We have previously shown that Trf1 gene 
expression was reduced with acute exercise in skeletal muscle (Ludlow et al. unpublished 
obs.).  In chronically exercised animals, exercise prevented an age-associated increase in 
TRF1 protein content and an age-associated decrease in TRF2 gene expression and 
protein content in skeletal muscle (Ludlow et al. under review).  Contrary to other tissues 
that undergo age-related telomere shortening, skeletal muscle telomere length does not 
change.  The increase TRF1 protein content observed in skeletal muscles older sedentary 
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animals may have protected/stabilized telomere length from shortening compared to 
shortened telomeres and lower TRF1 protein content in exercised animals.   
In the present study, we show that TRF1 protein content is not influenced by 
oxidative stress treatment in skeletal muscle fibers of C57BL/6 mice.  In the CAST/Ei 
fibers oxidative challenge alone did not change TRF1 protein content but the combination 
of antioxidant and oxidative stress increased TRF1 protein content, possibly indicating a 
bell shaped curve for TRF1 in response to ROS.  A moderate increase in ROS 
(combination treatment) may result in a permissive gene expression environment while a 
large increase in ROS may repress TRF1 expression (ROS treatment).  A study of 
skeletal muscle from Duchenne’s muscular dystrophy patients (a condition associated 
with increased skeletal muscle ROS) compared to control skeletal muscle showed TRF1 
protein was increased along with shortened telomeres (113).  We speculate that TRF1 is 
responding to ROS in a strain-specific fashion based on telomere length and the amount 
of telomere shortening.  We hypothesize that short telomere organisms (humans and 
CAST/Ei mice) may preferentially up-regulate TRF1 under stress while long telomere 
animals (C57BL/6) do not up-regulate TRF1 to stabilize telomere length in skeletal 
muscle.  Future antioxidant dose-dependent experiments are needed to clarify these 
findings.  
TRF2 protein content was increased in H2O2 treated skeletal muscle fibers of 
C57BL/6 animals but unchanged in CAST/Ei fibers.  Our results in C57BL/6 mice are in 
line with previous reports indicating that oxidative stress results in increased TRF2 
protein content (234).  The increase in TRF2 protein content could be a compensatory 
mechanism of the fibers attempting to prevent further telomere loss, since TRF2 is 
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important in telomere length homeostasis (185).  In addition, TRF2 is known to associate 
with several DNA damage sensing kinases, such as ATM (235), thus TRF2 could be 
mediating a DNA damage signal at ROS-induced shortened telomeres leading to 
telomere protection and repair (236).  These data indicate that TRF2 is associated with 
the response of ROS-induced telomere shortening in C57BL/6 skeletal muscle. TRF2 was 
not induced in short-telomere mice, possibly related to underlying differences between 
strains in either telomere biology and/or antioxidant capacity. 
The response of TRF1 and TRF2 protein content to oxidant challenge differed 
strikingly between mouse strains.  Long-telomere mice up-regulated TRF2 but not TRF1, 
while short telomere mice did not alter the expression of either protein with ROS 
treatment, but increased TRF1 with combined oxidant and antioxidant treatment.  The 
differential results between the CAST/Ei and C57BL/6 strains could be due to genotype 
or differences in telomere length (197,237).  Recent evidence indicates that there may be 
differences in the response to oxidative stress between species with different telomere 
lengths, possibly explaining our results (197).  The relatively recent inbreeding of the 
CAST/Ei strain compared to the long-term inbreeding of the C57BL/6 strain could 
represent evolutionary divergence within the species (197,238), which could also explain 
the differential results.   
 The current investigation is not without limitations.  Our data provide no insight 
into a time-course of change of telomere length or expression of telomere length-
maintaining proteins.  In addition, a greater dose of antioxidant would also provide 
significant depth to the current investigation given the CAST/Ei results by clarifying the 
response of TRF1 to ROS and NAC treatment.  This information would allow us to 
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determine if a greater dose of antioxidant would result in prevention of ROS-induced 
telomere shortening in the CAST/Ei strain. 
 In summary, we describe that ROS results in telomere shortening in skeletal 
muscle fibers of mice, but with strain-specific responses of shelterin components.  These 
data indicate important strain differences in the response of telomeres and telomere-
related proteins that may be driven by intrinsic differences related to telomere length 
and/or antioxidant enzymes or other unknown factors.  We provide a potential 
mechanism by which chronic exercise and its related ROS production, especially in the 
early, unaccustomed stages, could induce telomere shortening in skeletal muscle. 
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Tables 
Table 5.1.  Animal characteristics and strain comparisons. 






















Data are presented as mean ± S.E.M.  * P < 0.05. wks = weeks, g = grams, T/S ratio = 
telomere copy PCR to single copy gene PCR ratio.  Amoles = attomoles, AU = arbitrary 
units.  Age was significantly different between strains but not within strain between 
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Figure 5.1:  Morphology of skeletal muscle fibers cultured at physiologic oxygen and 
treated with hydrogen peroxide with and without antioxidant (NAC) for 5 days.  
Skeletal muscle fibers from both strains of mice were cultured in low oxygen conditions 
and treated for 5 days with H2O2 (1µM), H2O2 plus N-acetylcysteine (NAC, 10µM and 
1µM H2O2), or control (vehicle, water) treated.  Treatments were replaced every 24hrs.  
A) Micrographs of C57BL/6 skeletal muscle fibers cultured over five days at low oxygen.  
No visible differences were observed among treatment groups.  Images were taken at low 
(10x) and high magnification (40x) from an inverted light microscope.  The high 
magnification images show intact sarcomeric structure.  B) Micrographs of CAST/Ei 
fibers over five days at low oxygen.  Representative images are presented from each 
treatment group.  CONT = control; H2O2 = hydrogen peroxide treated; NAC+ = hydrogen 
peroxide and NAC treated. Scale bar on low magnification image = 1mm; high 
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Figure 5.2:  Oxidative stress shortens skeletal muscle fiber telomere length.  Skeletal 
muscle fibers from both strains of mice were cultured in low oxygen conditions and 
treated for 5 days with H2O2 (1µM), H2O2 plus N-acetylcysteine (NAC, 10µM and 1µM 
H2O2), or control (vehicle, water) treated. A. Telomere length as measured by T/S ratio.  * 
H2O2 significantly different from control (p = 0.05).  # H2O2 significantly different from 
NAC+ (p = 0.05). ¶ tendency for H2O2 to be different from control (p = 0.08).  Ŧ tendency 
for NAC+ to be different from control (p = 0.07).  B.  Telomere length expressed relative 
to each strain’s control condition to show the relative change in telomere length. Data are 
presented as means ± S.E.M.  CONT = control; H2O2 = hydrogen peroxide treated; 
NAC+ = hydrogen peroxide and NAC treated.  T/S ratio = Telomere repeat copy to 
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Figure 5.3: Oxidative stress does not alter telomerase enzyme activity in skeletal 
muscle fibers.  Oxidative stress treatment did not result in altered telomerase enzyme 
activity in either strain of mice (C57BL/6 p = 0.8; CAST/Ei p = 0.6).  Overall comparison 
between strains revealed greater telomerase enzyme activity in C57BL/6 compared to 
CAST/Ei animals (p < 0.01). Data are presented as means ± S.E.M.  CONT = control; 
H2O2 = hydrogen peroxide treated; NAC+ = hydrogen peroxide and NAC treated.  
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Figure 5.4:  TRF1 protein content is not altered by oxidative stress treatment.  In 
C57BL/6 fibers oxidative stress treatment did not alter TRF1 protein content (p = 0.9).  In 
the CAST/Ei mice there was no difference between CONT and H2O2 treated fibers (p = 
0.5).  NAC+ treated fibers had greater TRF1 protein content compared to CONT (p = 
0.04) and H2O2 (p = 0.01) treated fibers.  No significant difference was observed between 
strains for TRF1 normalized to GAPDH protein content (C57BL/6 0.43 ± 0.2 vs. CAST 
0.76 ± 0.2 AU; p = 0.4). Densitometric analysis and representative immunoblot images of 
TRF1 and GAPDH are shown.  GAPDH was a loading control.  Data are presented as 
means ± S.E.M.  CONT = control; H2O2 = hydrogen peroxide treated; NAC+ = hydrogen 
peroxide and NAC treated. AU = arbitrary units. # H2O2 significantly different from 
NAC+ (p < 0.05).  § CONT significantly different from NAC+ (p < 0.05). 
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 Figure 5.5:  TRF2 protein content is increased in response to H2O2 in C57BL/6 
muscle fibers.  C57BL/6 H2O2 treated fibers had increased levels of TRF2 protein 
content compared to NAC+ (p = 0.05) and tended to be greater than CONT (p = 0.1) 
fibers.  CONT and NAC+ fibers had similar TRF2 protein content (p = 0.3). In CAST/Ei 
animals treatment did not result in altered TRF2 protein content (p = 0.7).  No significant 
difference was observed between strains for TRF2 normalized to GAPDH protein content 
(p = 0.7). Densitometric analysis and representative immunoblot images of TRF2 and 
GAPDH are shown.  GAPDH was a loading control.  Data are presented as means ± 
S.E.M.  CONT = control; H2O2 = hydrogen peroxide treated; NAC+ = hydrogen peroxide 
and NAC treated.  AU = arbitrary units.   ¶ tendency for H2O2 to be different from control 
(p = 0.1).  # H2O2 significantly different from NAC+ (p = 0.05). 
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Supplemental Figure 5.1.  Low oxygen incubator leak test.  To ensure that the 
polystyrene container (equally impermeable to carbon dioxide (CO2) and oxygen (O2)) 
would maintain low O2, we filled three six-well plates with cell culture media and phenol 
red indicator dye.  Plate 1 was left on the lab bench at room temperature and ambient 
oxygen levels.  Plate 2 was placed in the 5% CO2, 37ºC and ambient O2.  Plate 3 was 
placed into the low O2 container, flushed with the low O2 gas mixture and left in ambient 
air and at room temperature.  The media will maintain its red-orange color if the 
container is airtight (i.e., maintaining 5% CO2 and the pH of the media such that the color 
does not change).  Therefore, if plate 3 was similar in color to plate 2, and different from 
plate 1 then the container was considered to be air tight and suitable to maintain low O2 
levels.  Plates 2 and 3 were similar in red-orange color, while plate 1 turned a purple 
color, indicating that 5% CO2 concentration was maintained.  This test showed that the 
incubator was not leaking and thus suitable to maintain 5%CO2 and ~2-5% O2 when 
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Supplemental Figure 5.2.  Hydrogen peroxide dose optimization at low and ambient 
oxygen levels.  C57BL/6 skeletal muscle fibers were isolated (n = 4 animals; 2 per 
oxygen condition) and allowed to incubate overnight in low oxygen or ambient oxygen in 
the cell culture incubator prior to hydrogen peroxide treatment.  The following day fibers 
were treated with control, 1µM, 10µM, or 25µM hydrogen peroxide.  Fibers were 
inspected on the following day (day 2 in culture).  Fibers treated with greater than 1µM 
were hyper-contracted and dead.  From these data we determined that 1µM hydrogen 
peroxide was the maximum tolerable dose that skeletal muscle fibers could tolerate for 
the 5-day treatment period.  A.  Fibers cultured at low oxygen levels (~2-5%).  B.  Fibers 
cultured at ambient oxygen levels.  Representative micrographs at low magnification 
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Chapter 6:  Summary and Conclusions 
Summary 
The studies performed for this dissertation have contributed the following new 
information: (1) long-term voluntary wheel running, a form of exercise training in mice 
that produces expected health-related benefits, results in telomere protection in heart and 
liver, but results in telomere shortening in skeletal muscle (Study #1); (2) acute exercise 
alters the expression of telomere binding proteins, a response that appears to be mediated 
in part by calcium activation of mitogen-activated protein kinases (Study #2); (3) reactive 
oxygen species (ROS) exposure results in skeletal muscle fiber telomere shortening (in 
the absence of satellite cell incorporation), increased telomere binding protein expression, 
and divergent telomere-related responses in mouse strains of differing telomere length 
(Study #3).  The combined results of these studies have further affirmed that exercise 
affects telomere biology, but in a tissue-specific and strain-specific manner.   
More specifically this dissertation has focused on the role of both acute and 
chronic endurance exercise and the effects of ROS on telomere biology in skeletal 
muscle.  Studies #2 and #3 attempted to define possible mechanisms for the interesting 
and paradoxical telomere shortening observed in skeletal muscle of chronically active 
mice (Study #1). Skeletal muscle contraction activates many pathways during acute 
exercise, two of the most well characterized being changes in calcium flux and the 
production of reactive oxygen species.  Both calcium and ROS have been linked to 
changes in gene expression in general and are considered vital second messengers in the 
adaptive responses in skeletal muscle.  Thus when skeletal muscle is induced to contract 
during an exercise stimulus, we speculate that the following events occur with regard to 
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telomere biology: increases in intracellular calcium activate p38 MAPK likely via a 
CAMK II mediated event, which leads to the repression of shelterin gene expression 
through activation or repression of undefined transcription factors; simultaneously, 
muscle contractions increase ROS production from NADPH oxidase and mitochondria; 
the combined effect of acute repression of shelterin components and increased ROS 
production leads to unrepaired telomere DNA damage; over time (the first several 
repeated bouts of unaccustomed exercise), reduced shelterin gene expression leads to 
lower levels of shelterin protein, exposing telomere ends to damaging ROS; skeletal 
muscle then responds to the chronic stress by increasing the expression of TRF2; as the 
skeletal muscle adapts to exercise training (i.e., repeated bouts over a sustained period of 
time) other systems such as antioxidant enzyme defenses are increased, leading to 
reduced ROS levels and possibly lower MAPK activation, thus leading to restoration of 
shelterin levels.  The end result is telomere length loss that likely occurred prior to the 
full adaptation of the skeletal muscle to the exercise stimulus.  Thus (as shown in Figures 
6.1 and 6.2), our data provide evidence for a model whereby calcium and ROS (via 
MAPKs) act to alter telomere binding protein expression in skeletal muscle that, along 
with ROS-induced telomere damage, results in reduced telomere length in response to 
repeated bouts of endurance exercise.  With chronic training the effect of ROS will be 
decreased by increased ROS scavenging by antioxidant enzymes such as glutathione 
peroxidase and superoxide dismutase, which in turn reduce MAPK signaling and increase 
telomere protection by TRF2. This model, which is limited to skeletal muscle in mice, 
will require substantial testing for confirmation but provides a basis for future work.  
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Figure 6.1.  Proposed mechanism of telomere shortening in skeletal muscle of 
animals exposed to acute exercise.  This model shows that unaccustomed exercise 
results in increased calcium and ROS within skeletal muscle cells.  Calcium results in 
activation of MAPKs, possibly via CAMKII, leading to reduced gene expression of TRF1 
and TRF2.  ROS likely adds to the activation of MAPKs.  The reduced expression of 
TRF1 and TRF2 leads to exposure of the telomere end, which is then more susceptible to 
the damaging effects of ROS and leads to telomere shortening.   
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Figure 6.2. Proposed mechanism of telomere shortening in skeletal muscle of 
animals exposed to chronic exercise.  This model shows that over time the skeletal 
muscle adapts to exercise training by increasing the expression of antioxidant enzymes 
thus increasing its ability to scavenge ROS.  In addition, we have shown that TRF2 
expression is increased in muscle of chronically exercised animals, which is expected to 
improve telomere protection. While calcium transients will still activate MAPKs, the 
additional activation stimulus from ROS will be diminished via scavenging leading to 
less of a repression signal for TRF1 and TRF2 gene expression. Thus, the majority of 
skeletal muscle telomere shortening in response to exercise is speculated to occur in 
response to the first several bouts of unaccustomed exercise with less shortening over 
time.   
 
Possible strain and species-specific considerations – The above model does not 
take into consideration the strain- and possible species-specific differences in telomere 
biology.  Recent reports and our data indicate that telomere length differences between 
mouse strains and species in general may dictate the response of telomere length to ROS 
exposure (197).  In addition consideration of telomere length may be important when 
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studying telomere repeat binding factors; for example, short-telomere mammals (mice, 
Study #3 and humans (113)) may respond to ROS by stabilizing telomere length with 
TRF1, while long-telomere mammals appear to respond by up-regulating TRF2 (Study 
#3).  In addition the function of TRF1 and TRF2 in skeletal muscle telomere dynamics is 
unclear and may not follow the negative regulator model proposed by the de Lange group 
(185).  The model put forth by de Lange and colleagues of TRF1 and TRF2 function has 
been studied almost exclusively in mitotic cell types, however, and thus may not be 
completely relevant to post-mitotic tissues, such as skeletal muscle.  Our data indicate 
that further study is needed to clarify the function of TRF1 and TRF2 in skeletal muscle 
in general and in species-specific contexts. These hypotheses require further testing, 
some of which is outlined below.   
Future Perspectives - Though the present studies provide important and novel 
findings on telomere biology and exercise, a number of important questions remain for 
future investigation. In general the mechanism of how exercise signals to the genome to 
produce a telomere length-reducing stimulus in skeletal muscle is largely unknown.  We 
have demonstrated that stress activated kinases (MAPKs) play a role in the response of 
telomere binding proteins to exercise; however, our data do not provide a mechanistic 
explanation of if or how exercise is directly reducing telomere length.  Studies #1 and 2 
point to a repeat-bout effect such that the transient acute effects of exercise may 
accumulate and result in the shortened telomeres seen after chronic exercise in skeletal 
muscle.  We have also shown that increased ROS exposure is a possible mechanism for 
telomere shortening in adult skeletal muscle.  These data indicate the need for follow-up 
long-term exercise interventions to study the rate of change in telomere length and 
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telomere-related components and whether ROS in vivo is a causative mechanism of 
telomere shortening in skeletal muscle.   
How is exercise reducing telomere length in skeletal muscle in vivo? Telomeres 
can shorten due to several factors including mitosis, unrepaired telomere DNA damage, 
and altered end-processing, the latter being more relevant to skeletal muscle due to its 
post-mitotic status (173).  Our group and other labs have demonstrated that endurance 
exercise contributes to telomere shortening in skeletal muscle ((7,109) Ludlow et al. 
under review).  We provide evidence that ROS could be a causative mechanism of 
telomere shortening in adult skeletal muscle fibers; however, these results need to be 
confirmed in vivo.  Exercise training enhances the antioxidant enzyme system of skeletal 
muscle (142), but long term exercise training may lead to the accumulation of ROS 
damage at the telomere leading to shortening.  To clarify these results the following 
experiments could be performed.  First, one would have to consider the model organism 
of choice, as results may vary depending upon strain of mouse or species chosen.  Human 
tissue experimentation would be preferred but genetic manipulation will be needed to 
clarify the mechanism of telomere shortening, thus mouse models will have to be used; in 
particular the CAST/Ei background would be preferred as this strain has telomere lengths 
most similar to humans (60).  To test if ROS produced during acute exercise is related to 
telomere shortening, genetically altering the antioxidant system specifically in skeletal 
muscle (e.g., loss of function experiments) and exercise training wild-type and knock-out 
animals will allow the dissection of whether or not ROS produced during acute and 
chronic exercise is a telomere shortening stimulus.  Since the knock-out animals would 
lack the ability to increase ROS scavenging with training, telomere shortening should be 
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greater in these animals compared to wild-type animals, thus providing in vivo evidence 
that ROS shortens telomeres in skeletal muscle.  In addition transgenic animals 
overexpressing antioxidant enzymes in skeletal muscle could be used to show protection 
against exercise training-induced telomere shortening.  Our data also showed that 
telomere shortening in skeletal muscle may be a function of the initial bouts of 
unaccustomed exercise, therefore future research is needed to determine the time-course 
of telomere length change in skeletal muscle fibers under oxidative challenge (i.e., 
exercise animals for 1 week, 3 months, 6 months, 1 year and longer).  Additionally, 
research in skeletal muscle (or other tissues) should pay particular attention to the 
frequency, intensity and duration of the exercise stimulus, as information pertaining to 
these variables is currently lacking. This could be clarified with similar knock-out and 
transgenic animals as mentioned above.   
Common telomere dogma states that telomere length in skeletal muscle only 
shortens in vivo when satellite cells are induced to proliferate, yet endurance exercise is 
not a satellite cell proliferative stimulus, so this mechanism is unlikely.  We showed that 
ROS is a telomere-shortening stimulus in skeletal muscle fibers devoid of satellite cells in 
vitro (Study #3).  An exciting new tool has recently been developed by McCarthy et al. 
(239) that allows the skeletal muscle-specific depletion of satellite cells by altering the 
expression of Pax7 in post-natal skeletal muscle. Using the Pax7 satellite cell depletion 
model would remove the possibility of satellite cell incorporation contributing to 
telomere shortening in skeletal muscle and the study of other telomere shortening 
mechanisms (e.g., ROS) could be elucidated in an intact organism.  Experiments with 
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skeletal muscle in these animals could lead to a mechanistic explanation for how exercise 
training results in telomere shortening in skeletal muscle.   
In addition future research is needed to determine if having short telomeres in 
skeletal muscle results in a dysfunctional phenotype. For example, do shortened 
telomeres in skeletal muscle reduce the ability of the skeletal muscle cells to contract 
when stimulated or repair cellular damage?  Collins et al. (109) provided some evidence 
of reduced endurance performance in fatigued athlete myopathic syndrome (in which 
shortened telomeres are observed) but the performance decrement could be due to factors 
other than short telomeres.  Important functions to test in skeletal muscle fibers with 
shortened telomeres would be their ability to undergo excitation contraction coupling, 
apoptosis susceptibility, fatigue resistance, and metabolic functions.  To clarify these 
questions one could perform experiments with late generation (G4-G6 mTERT or 
mTERC) knock-out animals with short telomeres in their skeletal muscles.  
Understanding whether or not a dysfunctional phenotype is associated with short 
telomeres in skeletal muscle results is a critical next step in this line of research.  This 
information is not only relevant to exercise-trained skeletal muscle but also to skeletal 
muscle conditions associated with short telomeres (e.g., muscular dystrophies), as 
telomere position effects in these conditions could play a substantial role in affecting 
gene expression.   
How is exercise affecting telomerase expression and activity in skeletal muscle?  
In our Study #1 of long-term exercised CAST/ Ei mice we observed greater telomerase 
enzyme activity in skeletal muscle homogenates of one-year old exercised animals 
compared to age-matched sedentary animals.  How exercise training resulted in increased 
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skeletal muscle telomerase lacks explanation; the expression and activity of telomerase is 
complex, due to multiple transcripts species-specific enhancers and repressors, and 
differences in telomere length between species (197).  Possible mechanisms of 
telomerase regulation by exercise include ROS-induced activation of Nfκβ, as TERT 
expression is linked to Nfκβ signaling (240), but these seem unlikely in skeletal muscle 
given Study #3’s results showing that ROS did not alter telomerase in either mouse 
strain. However, Study #3 was only five days long, therefore longer interventions with 
ROS manipulation are needed to fully elucidate the role of ROS in skeletal muscle 
telomerase activation.  
In addition, extra-nuclear actions of telomerase have been proposed (e.g., 
reduction of mitochondrial ROS), but not investigated with regard to exercise in skeletal 
muscle.  Manipulations such as exercising animals with normal (C57BL/6) length 
telomeres (e.g., G1-2 mTERT -/-) without the presence of telomerase could provide a 
unique way to investigate the role of telomerase in the adaptation of skeletal muscle 
telomeres to exercise.  A recent mouse model has been developed that allows the precise 
control of re-activating telomerase on a telomerase null background (101).  This animal 
model could be used to compliment the studies in mTERT -/- mice.  Important to all of 
these questions is the fact that skeletal muscle telomerase activity was very low and may 
not be important for telomere biology in this tissue, which should be addressed separately 
using the mTERT knock-out and transgenic (conditional and tissue-specific) mice (241).  
Understanding the role of telomerase in skeletal muscle will be important for diseases or 
conditions where the proliferative capacity of skeletal muscle progenitor cells is 
compromised.  
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What are the functions of Telomere-repeat binding factors 1 and 2 in post-mitotic 
skeletal muscle fibers?  The functions of TRF1 and TRF2 in skeletal muscle need 
clarification.  Our experiments resulted in conflicting findings in relation to the current 
knowledge regarding shelterin.  The majority of studies concerning TRF1 and TRF2 have 
been performed in proliferating tissues or cells such as human immune cells, human 
fibroblasts, human cancer cell lines (immortalized), or mouse embryonic fibroblasts (69).  
These studies have produced a model for the function of TRF1 and TRF2 in which these 
two shelterin components act as negative regulators of telomerase-dependent telomere 
elongation (185). In post-mitotic tissues, however, this model may not hold.  Evidence 
from Werner et al. (8,9) and Zhang et al. (236) show that post-mitotic tissues such as 
cardiac tissues and neurons respond to external stressors (i.e., exercise and ROS, 
respectively) by up-regulating shelterin, TRF2 specifically.  In all three dissertation 
studies we similarly observed altered expression of shelterin components in concert with 
changes in telomere length.  These findings require follow-up to clarify the roles that 
TRF1 and TRF2 are playing in skeletal muscle following acute and chronic exercise.  In 
addition, strain-specific telomere length seems to dictate the response of TRF1 and TRF2 
to ROS treatment, with long-telomere mice up-regulating TRF2 and short-telomere mice 
increasing TRF1 protein content. Thus consideration of strain will be important for 
translating any findings to the human condition.  
To further elucidate the importance of these proteins in skeletal muscle genetic 
manipulation is required.  TRF1 and TRF2 knock-out animals are embryonic lethal; 
however, the Blasco group has recently made several shelterin component tissue-specific 
knock-out animals.  Tissue-specific and conditional deletion and/or expression tools offer 
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exciting possibilities to elucidate mechanisms of shelterin gene function in specific 
tissues.  Muscle-specific deletion of TRF1 or TRF2 in combination with exercise stimuli 
may be used to determine the roles of these proteins in telomere function in skeletal 
muscle.  Moreover, TRF1 and TRF2 have extra-telomeric functions as well and these 
have yet to be explored in skeletal muscle of exercised animals (224,236). Improving our 
understanding of the role of these proteins in skeletal muscle may provide insights into 
skeletal muscle aging and diseases of skeletal muscle.   
 How is exercise regulating the expression of telomere binding proteins TRF1 and 
TRF2 in skeletal muscle?  We observed significant alterations in TRF1 and TRF2 gene 
expression and protein content in these studies.  We used acute exercise to manipulate the 
gene expression of these proteins.  Since acute exercise is a potent perturbation to 
homeostasis many signal transduction pathways are activated making in vivo 
identification of causative pathways nearly impossible, therefore in vitro analysis is 
needed.  Our in vitro results indicate that MAPKs may be involved in repression of 
shelterin genes.  Future studies manipulating the activity of the MAPKs and also 
identifying the exercise-induced signals (e.g., ROS or calcium) that result in these 
transcriptional changes are warranted.  The important response elements in the promoter 
regions of the shelterin genes are unknown.  Once the response elements in the promoters 
are identified, determining which transcription factors are responsible for altering the 
gene expression of shelterin would be possible.  Reporter gene assays for the rodent 
shelterin components would also be very useful in determining regulatory elements and 
important exercise-activated transcription factors.  Unfortunately, the reporter plasmids to 
perform this work are currently not available and will need to be constructed.  This 
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information will allow the testing of these pathways in vivo in conditional knockout, 
knockdown and transgenic models.  These gene regulation studies will compliment the 
information gained from the functional studies of TRF1 and TRF2 in skeletal muscle by 
providing potential drug targets aimed at altering the expression and function of these 
proteins in skeletal muscle.   
 How can we perform mechanistic studies of telomere biology in humans? As 
mentioned throughout this document, telomere biology differs in mice and humans.  For 
example, mouse telomeres (most strains) are much longer compared to humans and do 
not appear to limit cellular replication in vivo. Recent work has been aimed at 
determining the appropriate model organism for human telomere biology, but much work 
remains in this area.  Performance of telomere biology studies in humans is hampered by 
the long period of time needed to observe a detectable change in telomere length (on the 
order of decades) and, as with all research in humans, tissue samples are difficult to 
obtain.  With regard to skeletal muscle, recent advances in optimal culture conditions and 
certain genetic manipulations (hTERT and CDK4 transgene induction to bypass p53 
induced senescence and stasis, respectively) have allowed researchers to selectively 
immortalize skeletal muscle myoblasts from primary cultures of both healthy and 
diseased patients (242,243).  With this system in place clonal skeletal muscle cells can 
now be studied over long periods to ascertain information concerning cellular phenotypes 
related to telomeres.  Once the phenotypes are identified, biochemical and genetic 
manipulation can be used to develop treatments and also study environmental influences 
such as pathways activated in response to exercise or muscle contractile activity.  Similar 
technologies/strategies could be employed in other tissue types that are difficult to obtain 
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(e.g., cardiomyocytes).  In addition the advent of induced pluripotent stem (iPS) cells and 
directed differentiation of these cells (e.g., into myocytes) may make the study of human 
samples even more attractive, though not without limitations.  Evidence shows that iPS 
cells are epigenetically reprogrammed, have elongated telomeres compared to the tissue 
source from which they were derived, and also re-express telomerase at levels similar to 
native stem cells.  These issues provide a roadblock to using iPS cells in telomere related 
research.  
Conclusions 
Overall we conclude that chronic exercise is related to reduced skeletal muscle 
telomere length, and that both acute and chronic exercise alter telomere binding protein 
expression in mouse skeletal muscle.  We provide evidence for a role of the MAPK 
protein family in the exercise-induced expression of telomere binding proteins and also 
demonstrate in skeletal muscle that Ca2+-induced signaling and ROS are important 
mediators of skeletal muscle telomere biology.  Calcium appears to be related to 
activation of signaling pathways associated with expression of shelterin, while ROS 
appears to be related to both signal transduction and to direct telomere shortening in 
skeletal muscle.  While we provide evidence that telomere shortening occurs in muscle 
fibers in response to these stimuli, we do not know if this shortening has any functional 
outcome at the level of the telomere (e.g., telomere position effects) or at the level of the 
muscle fiber.  In the present studies we provide substantial evidence that exercise and 
exercise-related signaling are associated with altered skeletal muscle telomere biology, 
which may prove important for understanding post-mitotic tissue aging and disease 
susceptibility.    
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Supplemental expanded methods 
Telomere Length Measurement  
 Measurement of relative telomere lengths (T/S ratios) was determined by quantitative 
real time polymerase chain reaction (RT-PCR) as described by Cawthon (176) with the 
following modifications. The forward primer for the telomere PCR was tel1b [5’-CGG TTT 
(GTTTGG)5 GTT-3’] used at a final concentration of 125 nM. The reverse primer was tel2b 
[5’- GGC TTG (CCTTAC)5 CCT-3’] used at a final concentration of 312.5 nM.  S PCR 
(mouse acidic ribosomal phosphatase PO, 36B4; Forward 5’- AAC AAG GCA GGA 
GTG AGA CTG; Reverse 5’- CCA GGG ATA CGG GAG AAA A).   SYBR Green 
Master mix (Applied Biosystems) was used and added to 8.75µL of sample and standard 
DNA. Tubes containing 50, 25, 12.5, 6.25 and 3.125 ng/µL of reference DNA were included 
in each PCR assay so that the quantity of research sample DNA could be determined relative 
to the reference DNA sample by the standard curve method (Figure A.1.). The same 
reference DNA was used in all PCR runs.  Cycling conditions for the T PCR were 50ºC for 
2 min, 95ºC for 10 min followed by 30 cycles of 95ºC for 10 sec and annealing at 56ºC 
for 1 min with data collection.  Conditions for the S PCR were 50ºC for 2 min, 95ºC for 
10 min, 35 cycles of 95ºC for 15 sec, annealing at 56ºC for 1 min with data collection, 
extend 72ºC for 1 min. followed by a dissociation stage of 95°C for 15sec., 60°C for 30 sec., 
95°C for 15 sec to ensure specificity of products. The assay was performed using an Applied 
Biosystems 7300 Real Time PCR System (Applied Biosystems, Foster City, CA).  A plot of 
Ct versus log (amount of input reference DNA) is linear and was used to determine the 
integrity of the assay. The Ct value is the fractional cycle number at which the fluorescence 
emitted by the sample crosses a set threshold that is above the baseline fluorescence (26). The 
 
  151 
Telomere PCR (T-PCR) to Single copy gene PCR (S-PCR) ratio was derived from the Ct 
values of each unknown sample relative to a reference sample in each assay via the method 
of Livak (244). The ratio of telomere repeat copy number to a single copy gene copy number 
allowed the relative quantification of PBMC telomere length. This ratio was proportional to 
the average telomere length.  The T/S ration was determined according to the following 
formula: 
2-ΔΔCt = 2 ^ - (CT unknown telomere copy PCR- CT reference telomere copy PCR) - (CT 
unknown single copy PCR - CT reference single copy PCR). 
 
 
 Figure A.1.  Telomere PCR and Single-copy gene PCR standard curves.  T PCR Ct = 
telomere PCR critical threshold. S PCR Ct = single cope gene PCR critical threshold.  
Log10 [DNA] = logarithmic scale base 10 concentration of DNA. 
 
Terminal restriction fragment length analysis of telomere length - Briefly, 2µg of 
genomic DNA was digested overnight with Rsa1 and HpaIII  (Roche, Indianapolis, IN) 
y = -2.0995x + 22.328 












Log 10 [DNA] 
y = -2.9306x + 25.661 















  152 
and electrophoresed on 0.7% agarose gels for 2hrs and visualized via ethidium bromide 
staining.  The gel was then electrophoresed for 16hrs at 60v to ensure adequate separation 
of DNA fragments.  The DNA was blotted onto positively charged Nylon membranes 
(Roche, Indianapolis, IN), heat cross-linked and hybridized overnight at 50ºC with the 
telomeric probe (digoxigenin 3′-end-labeled 5′-(CCTAAA)3) and visualized using a 
chemiluminescence detection system (Syngene Bio Imaging, Frederick MD; Supporting 
Figure 1).  Mean, median, minimum and maximum TRFs were determined according to 
previous methods (178). We generated conversion equations from the resulting TRFs to 
convert T/S ratio data into kilobase data by plotting the T/S ratio of each respective 
sample versus the corresponding kilobase measurement from the TRF assay.  
Representative image (Supplemental Figure 3.1). 
Telomerase enzyme activity determination 
 The following section will outline the measurement of telomerase enzyme activity. 
Measuring telomerase can be done in a few different methods relying on the telomere repeat 
amplification protocol (TRAP) (179) or an enzyme linked immunosorbant assay (ELISA). 
For the present studies we chose the TRAP that utilized real-time PCR amplification and 
emitted fluorescence as the means for quantifying telomerase enzyme activity. The assay 
uses two fluorometrically labeled primers that when incorporated into the TRAP product emit 
fluorescence and allow for simple quantification of telomerase activity. This procedure 
eliminated isotopic, gel- based and ELISA complications and the risk of carryover 
contamination since the fluorescence are measured directly from the reaction vessel. Briefly, 
a reaction mixture containing a template stand and primers is added to the PBMCs and PCR 
is performed. During the PCR the telomerase, if active in the cell sample, will add the 
fluorescently labeled primers to the template strand. During PCR amplification the 
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fluorescence reaction will occur and accumulate as more primers are added by telomerase. 
Figure A.2 below shows a schematic of this process.  
 
Figure A.2. A. Showing the addition of telomere repeats by telomerase. B. The synthesis of 
complimentary strand during the first cycle of PCR. C. Amplification of the product and the 
activated fluorescence. D. Accumulation of the activated product allowing for visualization 
with the appropriate software. Figure adopted from the TRAPeze kit insert, Chemicon 2000. 
 
The assay procedures followed the recommendations of the manufacturer. Briefly, after the 
cells/ tissues were prepared at a protein concentration of 1µg, a reaction mixture was made 
containing master mix, sample and PCR grade water.  Samples consisted of unknowns, heat-
treated unknowns, HeLa cell positive control, HeLa heat-treated, and standard provided in 
the kit. The plate was then loaded into the ABI 7300 RT-PCR machine and PCR performed 
with the following thermocycling profile 30°C for 20 min, 95°C for 2 min followed by 35 
cycles of 95°C for 15s, 60°C for 60s, 45°C for 32s. The telomerase PCR extension and 
57 
reaction will occur and accumulate as more primers are added by telomerase.  Figure 1 
below shows a schematic of this process.   
Figure 1.   
 
Figure 1.  A. Showing the addtion of telomeris repeats by telomerase.  B.  The 
synthesis of complimentary strand during the first cycle of PCR.  C.  Amplification of the 
product and the activated fluoresc n .  D.  Accumulation of the activated product 
allowing for visualiztion with the appropriate software.  Figure ad pted from the 
TRAPeze kit insert, Chemicon 2000.  
 
  PBMCs isolated and stored at -80°C were thaw d at 37°C, washed 3 times with 
10mL of 4°C PBS, and resuspended in 1mL of 4°C PBS.  Approximately 1x105  - 1x10
6
 
cells were suspended in 500µL of CHAPS lysis buffer.  The assay procedures followed 
the recommendations of the manufacturer.  Briefly, after the cells are prepared as stated 
above, a reaction mixture was made containing Titanium taq buffer, Trapeze master mix, 
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fluorescence took place in the reaction vessel. The fluorescence was detected by the ABI 
7300 and quantified by the software provided by ABI and a critical threshold (Ct) value 
determined. The enzyme activity will be determined following the standard curve method. 
From a standard sample provided in the kit, seven standards will be diluted with a 
concentration ranging from 0.5 amoles/µL to 0.0000064 amole/µL.  A plot of log(TSR 
concentration) versus Ct value is linear (Figure A.3.). By inserting each unknown’s Ct value 
into the X value of the linear standard curve and algebraically solving, one can determine 
each unknown’s enzyme activity in amoles.   
 
Figure A.3.  Telomerase PCR standard curve.    
y = -2.2665x + 20.486 
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Reverse-transcriptase PCR gel electrophoresis analysis 
 Gene expression analysis concerns determining the amount of expression of a gene 
product in the form of messenger RNA (mRNA).  To do this total RNA was extracted with a 
Guanidinium thiocyanate-phenol-chloroform method (245).  Following isopropanol 
precipitation and ethanol wash, total RNA was re-hydrated in tris-EDTA (TE, pH. 8.0) 
buffer. The concentration and relative purity of the RNA was determined 
spectrophotometrically use the absorbance at 260 and 280nm in the ultraviolet light 
spectrum.  Using the following formula, 1µg of total RNA was reverse transcribed to 
complimentary DNA.   
Formula: [RNA] in µg/µL = (A260 * dilution factor *40)/1000 
Where 40 is a conversion factor for single stranded nucleic acids 
Dilution factor is the dilution of RNA used in the spectrophotometer. 
A260 is the absorbance of the nucleic acid solution at 260nm (UV light). 
 
Once the cDNA was attained PCR reactions with gene and protein coding transcript specific 
primers were performed.  Several optimization reactions were undertaken to ensure specific 
binding and the ability of the primer pairs to detect a difference in the linear range of the PCR 
reaction.  First we determined the appropriate buffer to attain specific binding (i.e., a single 
amplicon band detected on the agarose gel).  Second a PCR cycle analysis was performed to 
determine the appropriate number of PCR cycles to ensure the amplicon was in the linear 
range of the PCR reaction (Figure 4.A).  Next we tested the ability of the primer pair to detect 
an increase in cDNA available to bind.  To do this we added various amounts of cDNA from 
the same sample and performed the PCR reaction with the goal of detecting a ~2-fold 
difference between amount of cDNA added.   
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Figure A4.  Gene expression primer linearity optimizations.  Each gene expression primer 
pair was optimized for cycle (data not shown) and then to ensure linearity of primers, 0.5µL, 
1µL and 2µL of 1µg cDNA was added to each PCR reaction and resolved on a 2% agarose 
gels.    
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Immunoblotting 
In general proteins were isolated (from tissues or cells), separated on sodium-dodecyl sulfate 
poly-acrylamide gels by electrophoresis, wet-electrotransferred onto PVDF membranes, 
probed with primary antibodies directed towards targets of interest, and enzyme linked 
secondary antibodies directed towards primary antibody species specific immunoglobulins 
for visualization purposes.  Two different total protein lysis buffers were utilized in this 
dissertation, a general lysis buffer for investigation of total cellular proteins (both nuclear and 
cytoplasmic) and the second more specific for studying post-translational modifications, such 
as phosphorylation of proteins.  Below are the methods utilized to optimize and validate the 
immunoblots in this dissertation work.   
 TRF1 and TRF2– Telomere-repeat binding factor 1 and 2 are chromatin bound 
proteins that are involved in stabilizing chromosome ends, regulating telomere length, and 
progression through the cell cycle.  To determine the protein content of these proteins the 
following methods were employed.  
 Total protein was isolated from skeletal muscle, cardiac muscle or liver tissues.  
Protein concentration determined via a BCA protein assay.  To determine the amount of 
protein necessary to detect TRF1 and 2 proteins, a range of protein concentrations were 
loaded onto a SDS-PAGE and immunoblotted as described above.  Figure A. 4 shows the 
detectable range of protein concentrations in liver tissue for TRF1 and TRF2.  In addition we 
determined non-specific bands by probing membranes with only primary or only secondary 
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Figure A.5. Linearity confirmation of TRF1 and TRF2.  Lad. = molecular weight marker 
or ladder.  NS = non-specific protein band.  This was confirmed to be non-specific with a 
secondary only antibody check.  Secondary was not changed due to the large difference in 
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